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SUMMARY 
 
Theory of aging postulates that aging is a remodeling process where the body of 
survivors progressively adapts to internal and external damaging agents they are 
exposed to during several decades.  
Thus , stress response and adaptation mechanisms play a fundamental role in the aging 
process where the capability of adaptating effects, certainly, also is related the lifespan 
of  each individual.  
        A key gene linking aging to stress response is indeed p21, an induction of cyclin-
dependent kinase inhibitor which triggers cell growth arrest associated with senescence 
and damage response and notably is involved in the up-regulation of  multiple genes 
that have been associated with senescence or implicated in age-related . 
 
This PhD thesis project that has been performed in collaboration with the Roninson Lab 
at Ordway Research Institute in Albany, NY had two main aims: 
-the testing the hypothesis that p21 polymorphisms are involved in longevity 
-Evaluating  age-associated differences in gene expression and transcriptional response 
to p21 and DNA damage 
  
In the first project, trough PCR-sequencing and Sequenom strategies, we we found out 
that there are about 30 polymorphic variants in the p21 gene.  
In addition, we  found an  haplotpype  located in -5kb region of the p21 promoter whose 
frequency is ~ 2 fold higher in centenarians than in the general population (Large-scale 
analysis of haplotype frequencies is currently in progress). 
        Functional studies I carried out on the promoter highilighted that  the ―centenarian‖ 
haplotype doesn’t affect the basal p21 promoter activity or its response to p53. 
However, there are many other possible physiological conditions in which the 
centenarian allele of the p21 promoter may potentially show a different  response (IL6, 
IFN,progesterone, vitamin E, Vitamin D etc). 
 
In the second part, project #2, trough Microarrays we seeked to evaluate the differences 
in gene expression between centenarians, elderly, young in dermal fibroblast cultures 
and their response to p21 and DNA damage. 
Microarray analysis of gene expression in dermal fibroblast cultures of individuals of 
different ages yielded a tentative ―centenarian signature‖. 
A subset of genes that were up- or downregulated in centenarians showed the same 
response to ectopic expression of p21, yielding a putative ―p21-centenarian‖ signature. 
            Trough RQ-PCR  (as well Microarrays studies whose analysis is in progress) we 
tested the DNA damage response of the p21-centenarian signature genes showing a 
correlation stress/aging  in  additional sets of  young and old samples treated with p21-
inducing drug doxorubicin thus finding for a subset of  of them , a response to stress 
age-related. 
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CHAPTER 1:  
 
1.1 Definition of Aging  
Aging is a complex process involving the additive effects of many genetic pathways 
(Kirkwood and Austand, 2000). It can be also defined as a progressive functional 
decline, , a gradual deterioration of physiological function, including a decrease in 
fecundity (Partridge and Mangel, 1999), or the intrinsic, inevitable, and irreversible 
process of loss of viability and increase in vulnerability (Comfort, 1964).  
        Clearly, human aging is associated with a wide range of physiological changes that 
not only make us more susceptible to death but that limit our normal functions and 
render us more susceptible to a variety of diseases.  
Over the years, many theories have emerged to explain what changes lead to aging 
(reviewed in Medvedev, 1990): different theories of aging are not mutually exclusive 
and may adequately describe some or all features of the normal aging process alone or 
in combination with other theories.  
Theories formultated to explain aging processes have been grouped into several 
categories some of the most widely used being the programmed and error theories of 
aging (reviewed in Weinert and Timiras, 2003). The table belove summarize the main 
characteristics of the major theories on aging.(from Winert and Timiras, 2003) 
 
 
Table n.1.1 
table n.1 main characteristics of major theories on aging (from Winert and Timiras , 2003) 
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1.2 Brief overview of main theories og aging 
 
According to the “programmed” thoeries, aging depends on biological clocks 
regulating the timetable of the life span trough the stages of growth, development, 
maturity, and old age.: this regulation would depend on genes sequentially switching on 
and off signals to the nervous , endocrine, and immune systems responsible for 
maintenance of homeostasis.  
The”error” theories identify enviromental insults to living organisms that iduce 
progressive damage at carious levels (e.g. mitochondrial DNA damage, oxygen radicals 
accumulation, cross-linking). 
           Evolutionary theories argue that aging results from a decline in the force of 
natural selection. Because evolution acts primarily to maximize reporductive fitness in 
an individual, longevity is a trait to be selected only if it beneficial for fitness.  
Among the evolutionary theories it has to be highlighted the Disposable Soma and the 
theory of antagonistic pleiotropy. 
The basic idea of the first one argues that somatic organism is effectly mainained only 
for reproductive success: afterward it is disposable. Inherent in this theory is the idea 
that somatic maintenance, in other word, longevity has a cost : the balance of resouces 
invested in longeviti vs reproductive fitness determines the life span. 
        The Antagonistic pleiotropy theory suggests that some genes may be selected for 
beneficial effects early in life and yet have unselected deleteroius effects with age, 
thereby contributing directly to the aging phenotype.  
 
The Molecular theories argue that the gene regulation theory of aging proposes that 
aging results from changes in gene expression (Kanungo MS, 1975). Life span is 
influenced by the selection of genes that promotes longevity: recently DNA microarrays 
have been used to assay genome-wode trascriptional changes qith age in seveal models. 
In the section belove, Microarrays and aging, I will discuss it more into detail. 
 
 The  main cellular theories are the cellular/senescence one and the free radical. 
The first one was formulated when cell senescence was described as the process that 
limits the number of cell divisons in normal human cells can undergo in culture 
(Hayflick L, 1965). This imit in replicative capacity occurs afer a characteristicc 
number of cell divisions and results in terminally arrested cells with altered physiology. 
(Campisi J., 2003). 
Cellular senescence can also occur in response to distict molecular events such as in 
response to a variety of stressors, including but not limited to 1) DNA damage2) 
modications in heterochromatin structure and 3)strong mitogenic signals resulting from 
oncogene expression (Campisi J., 2003) 
Cell expressing stress induced markers found in senescent cells accumulate with age in 
many tissues (Dimri GP, 1995 ; Krtolica A, 2002). Althoug it remains uncelar whether 
this indicates the presence of senescent cells in vivo. Several studies suggest that 
atherosclerosis results from senescent changes in arterial endothelial cells (Chang E et 
al., 1995 ; Fenton M, et al., 2001; Krtolica A and Campisi J., 2001). 
The altered physiology of senescent cells might contribute to aging and cancer through 
secondary effects on neighboring cells in tissues (Krtolica A and Campisi J., 2001). 
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P21, as I will discuss in the next session, is a CDK inhibitor and stress responsive gene 
which plays and important role in the senescent phenotype. 
     The free theory of aging is one of the best known theories and remains controversial 
to this day. All organisms live in an environment that contains free radical-containing 
reactive oxygen species (ROS): mitochondrial respiration, the basis of energy 
production, generates ROS by leaking intermediate from the electron transport chain 
(Finkel T and Holbrook NJ., 2000). 
This theory supposes that free radical reactivity results in cumulative damage and 
senescence. 
 In fact, elevated levels of both oxidant-damaged DNA and protein are found in aged 
organisms (Beckman KB and Ames BN, 1998; Shringarpure R and Davies KJ, 2002). 
An age dependent reduction in the ability to degrade oxidatively modified proteins may 
contribute to the build-up of damage, dysfunctional molecules in the cells (Shringarpure 
R and Davies KJ, 2002). 
Also mutation in mitochondrial DNA accelerates free radical damage by introducing 
altered enzyme components into the electron transport chain. Faulty electron transport 
results in elevated free radical leakage and ultimately more mitochondrial DNA 
mutation and exacerbated oxidant production. This cycle of mutations and oxidant 
production eventually leads to cellular catastrophe, organ failure, and senescence 
(Mandavilli BS et al., 2002).   
 
System based theories of aging” neuroendocrine and immune theories 
 
This theories argues that aging process is related to the decline of the organ system 
essential for 1)central and maintenance of the other systems within an organism and 
2)the ability of organisms to communicate and adapt to the environment in which they 
live. 
The nervous, endocrine and immune system play a key role in their interactive and 
defensive responsiveness to eternal and internal stimuli. 
For example the Neuroendocrine theory proposes that aging is due to changes in neural 
and endocrine functions that are crucial for 1)coordinating communication and 
responsiveness of all body systems with the external enviroment 2) programming 
physiological responses to enviromental stimuli and 3) maintaining an optimal 
functional state for reproduction and survival while responding to enviromental 
demands. 
 
 
Inflammaging 
 
The term "Inflammaging" has been coined by Claudio Franceschi to explain the now 
widely accepted phenomenon that ageing is accompanied by a low-grade chronic, 
systemic up-regulation of the inflammatory response and that the underlining 
inflammatory changes are also common to most age-associated diseases (Franceschi C, 
et al., 2000; Vasto S et al., 2006) 
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The inflammatory scenario that characterizes inflammaging constitutes a highly 
complex response to various subtle internal and environmental inflammatory stimuli 
mediated mainly by the increased circulating levels of pro-inflammatory cytokines. 
Inflammaging also generates Reactive Oxygen Species (ROS) causing both oxidative 
damage and eliciting an amplification of the cytokines' release, thus perpetuating a 
vicious cycle resulting in a chronic systemic pro-inflammatory state where tissue injury 
and healing mechanisms proceed simultaneously and damage slowly accumulates 
asymptomatically over decades and is a major determinant both of the ageing process 
and of the development of age-associated diseases (De Martinis M, et al., 2005;  
Franceschi C et al.,  1995) 
         Moreover, Claudio Franceschi, Tom Kirkwood, and Calogero Caruso as well as 
other authors, postulate that both the ageing process and age-associated diseases are late 
consequences of evolutionary programming for a pro-inflammatory response mainly 
selected to resist infections and for a successful response to wound healing in early age, 
a view that has been discussed in the light of the antagonistic pleiotropy theory as 
explained above (Van Den Biggelaar AHJ, et al., 2004; Vasto S,et al., 2006) 
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CHAPTER 2:Microarrays studies in aging  
 
To embrace the complexity of aging, an attractive approach is to use DNA microarrays 
to scan the entire genome for genes that change expression as a function of age or under 
conditions when longevity is extended.  
Expression data from DNA microarrays are quantitative, and thus it is possible to 
compare age related transcriptional profiles between different tissues, between different 
conditions that affect longevity and even between diverse species. 
Combining DNA microarrays results on aging from multiple labs, will be a powerful  
Insight into the complex mechanism of aging and longevity. 
 
Many DNA microarrays experiments have analyzed aging in various human tissues. 
(reviewed by Kim, 2007) 
Table belove contains references that profile gene expression changes in eight human 
tissues and two human progerias. 
 
Human 
 
Hutchison-Guilford 
Progeria syndrome 
 
Werner’s syndrome 
Brain 
(2004);  
 
fibroblasts 
 
kidney 
 
muscle 
et al. (2006) 
  
liver 
 
eye 
 
 
skin 
 
blood 
 
 
 
 
 
Cao et al. (2001) 
 
Ly et al. (2000); Kyng et al. (2003) 
Blalock et al. (2004); Lu et al. (2004);  Ricciarelli et al.  
 
Fraser et al. (2005); Liang et al. (2006) 
Kim et al. (2003)     
Rodwell et al. (2004); Melk et al. (2005) 
 
Welle et al. (2001, 2003, 2004); Giresi  et al. (2005); Zahn  
 
 
Thomas et al. (2002) 
 
Yoshida et al. (2002); Hawse et al. (2004); Segev et al. (2005) 
 
 
Lener et al. (2006) 
 
Visala Rao et al. (2003); Tan et al. (2005) 
 
 
Table 2: references for microarrays studies on aging  
 
2.1 Trascriptional profiles as markers for human aging 
 
Rodwell et al.m (2004) in their analysis of kidney aging showed that age-regulated 
markers could predict physiological age. 
They used Affymetrix genechips to measure levels of gene expression in kidney 
samples from 72 patients between 27 and 92 years old  age, and they identified a set of 
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447 age regulated genes. Next, they tested whether the over-all level of expression of 
the 447 genes was a signature of physiological age for different individuals.  
The relative amount of physiological aging for each of the patients used in the study 
was measured by examining the morphological and histological appearance of the 
kidney. A remarkable similarity was found between the transcriptional aging profiles 
and the physiological states of the kidney in different individuals.  
Some elderly persons displayed an aging signature similar to that of people who were 
30-40 years younger, and these individuals also had relatively healthy kidneys. Others 
displayed an aging signature similar to people who were 10-20 years older, and these 
patients showed poor kidney health.  
 
A similar experiment was performed by Zahn et al., to analyze aging of human muscle. 
They identified a set of 250 age-regulated genes in skeletal muscle from 81 patients 
ranging from 16 to 89 years of age. As muscle ages, there is a shift in the relative 
numbers of type II (slow twitch) to type I( fast twitch) muscle fibers , and the type 
II/type I muscle fiber ratio can be used as a rough estimate of the physiological age of 
the muscle. Similar to the aging expression profile for the kidney, the overall expression 
behavior of this set of age-regulated muscle genes correlated with the physiological as 
well chronological age of the muscle sample (Zahn et al. 2006). 
In summary these results indicate that the overall expression behavior of the age 
regulated kidney and muscle genes is a biomarker that depicts the physiological age in 
human kidney or muscle.  
  
 
2.2 Mitotic misregulation and human aging 
 
Ly et al., studied gene regulation of normal and premature aging in actively dividing 
cells. Messanger RNA levels were measured in actively dividing fibroblasts isolated 
from young, middle-age, and old-age humans and humans with progeria. The data 
obtained suggest that an underlying mechanism of aging process involves increasing 
errors in the mitotic machinery of dividing cells in the post reproductive stage of life. 
Ly et al., proposes that this dysfunction leads to chromosomal pathologies that result in 
misregulation of genes involved in aging process.  
 
Summarizing their Microarrays data revealed a set of gene that correlate with, and 
hence likely contribute to, age related phenotypes and diseases and suggest that mitotic 
errors in dividing cells may lead to the altered expression of these collection genes.  
 
 
2.3 DNA damage and human aging 
 
A long –held view is that accumulation of somatic mutations plays a a key role in 
decreasing cellular function in old age. 
Recent genomic studies by Lu et al. (2004) have provided intriguing new evidence for 
the role of DNA damage in aging of the human brain.  
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In their study, they used post-mortem samples of the frontal polo of 30 individuals 
ranging in age from 26 to 106 and found about 440 genes that change expression with 
age.  
They then measured the rate of aging by examining changes in gene expression at 
different points during life. Interestingly they found that most of the age-related changes 
occurred in people between 43 and 73 years old. Gene expression patterns in the brain 
were more consistent in the young and the old, but showed large variability in people 
were middle-aged. 
              Next Lu. Et al. asked whether DNA damage may have a role in age related 
changes in gene expression. They devised a PCR-based assay to measure levels of 
damaged DNA in brain samples from old and young patients. They isolated genomic 
DNA from brain samples ad then treated it with formamidopyrimidine-DNA 
glycosylase (FPG), which is an N-glycosidase and AP-lyase that selectively releases 
damaged bases from DNA.  
Damaged DNA would be selectively cleaved by FPG and would show lower levels of 
amplification in a PCR assay. They examined the promoters of 30 different genes and 
they observed that DNA damage targeted the promoter of genes that are repressed with 
age but did not affected or that increase expression with age.  
Lu. Et al. suggested that selective DNA damage gene promoter sequences is a potential 
mechanism whereby the expression of specific genes could register the passage of time.           
 
These findings also suggest that accelerated DNA damage may contribute to reduced 
gene expression in the human brain after age 40.  
There may be sites in the genome that are exceptionally prone to DNA damage, based 
on chromatin accessibility and GC content. These sites would be expected to include 
promoter regions which have high –GC content and are not protected by transcription –
coupled repair. Genes that are located near hot spots for DNA damage may show 
decreased expression levels in old age due to high levels of stochastic DNA damage.  
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2.4  Common pathways for aging in diverse tissues  
 
Some aspects of aging only affect specific tissues; examples include progressive 
weakness of muscle, declining synaptic function in the brain, and decreased filtration 
rate in the kidney. Other aspects of aging occur in all cells regardless of their tissue 
type, such as the accumulation of oxidative damage, DNA damage, and telomere 
shortening.   
 
Genome-wide searches for gene expression changes during aging would include both 
types of expression changes, and it would be interesting to discern which expression 
changes are tissue-specific and which are common to all tissues. 
            Genes that are age-regulated in all tissues would reveal genes involved in 
core mechanisms that underlie cellular aging.  
Several papers have found similarity in the transcriptional  aging profiles of different 
parts of the same human tissue. Rodwell et al. (2004) found that the transcriptional 
profiles for aging in the cortex and medulla of the kidney were very similar. Likewise, 
Fraser et al. (2005) found that age-related gene expression changes were similar 
between five different regions of the human cerebral cortex. However, they did not find 
any evidence for similarity between age-related expression changes in the cerebral 
cortex and in the cerebellum. 
       Recently, Zahn et al. (2006) have discovered genetic pathways that show common 
age regulation in kidney, brain, and muscle. They used Affymetrix GeneChips to 
analyze expression in 81 skeletal muscle samples from patients aged 16 to 86 years and 
found 250 age-regulated muscle genes. Next, they compared their muscle-aging results 
to previously published data on kidney and brain aging. 
Although most of the age-related changes were tissue specific, they found evidence for 
common age regulation of five genetic pathways in all three tissues. Specifically, there 
is an overall increase in expression of the extracellular matrix genes, the cell growth 
genes, and complement activation genes in all three tissues. 
Conversely, there is an overall decrease in expression of chloride transport genes and 
electron transport genes in all three tissues. 
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2.5 Comparison of aging patterns across species  
 
DNA microarray experiments have defined molecular profiles for aging for worms, 
flies, mice, rats, monkeys, and humans. An important question to answer is which parts 
of the aging transcriptional profile are shared between species (public) and which are 
specific for only one species (private). On the one hand, many biological processes 
involved in aging are shared across diverse species.  
    For example, oxidative stress and DNA damage have been postulated to play a role in 
aging in nearly all animals. Caloric restriction or mutations in genes such as the insulin-
like receptor gene (daf-2) or sir2 affect longevity in diverse species from yeast to mice. 
These common themes for aging suggest that there might also be genes that show 
common patterns of age regulation in different species. 
 
On the other hand, evolutionary theory postulates that there should be little or no 
overlap in the particular degeneration pathway of one species with that of distantly 
related species. Unlike most other biological processes, there is strong reason to believe 
that the aging process is not evolutionarily conserved per se (Kirkwood and Austad 
2000). As a rule, wild animals do not live long enough to grow old. For example, more 
than 90% of mice die in their first year in the wild, and thus, only a very small fraction 
of wild mice achieve their maximal life span of 3 years (Kirkwood and Austad 2000). 
The median human life span in the United States was 47 years in 1900 (Statistics 2006), 
and relatively few individuals lived to maximal life span during human evolution 
(Martin 2002). In the wild, life span is limited by disease and predation, not by aging 
Events that occur late in life escape the force of natural selection, and the aging process 
is unlikely to be evolutionarily conserved per se. 
Thus, there is little reason to believe that genetic and molecular events which occur late 
in life in model organisms such as the mouse would be conserved in humans. 
 
Early work by McCarroll et al. (2004) characterized gene expression profiles for normal 
aging in flies and worms.  
These investigators reported several biological processes that seemed to share a similar 
overall pattern of change with respect to age in flies and worms. However, the shared 
similarity between flies and worms is probably not related to aging, as most of the 
expression changes occur in young adults rather than old animals. Furthermore, the 
analysis used in the paper was flawed becauseit greatly overestimated the statistical 
significance of the results (Melov and Hubbard 2004). Nevertheless, this early paper 
contained a number of insightful ideas about ways to analyze large-scale gene 
expression data and to compare emergent properties from transcriptional profiles of 
aging across different species. 
Zahn et al. (2006) compared transcriptional profiles for aging in human to aging profiles 
for mice, flies, and worms. They asked whether any of the biological processes that 
showed age-dependent changes in expression in human also showed similar age 
regulation in mice, flies, or worms.  
Of the five genetic pathways that were age-regulated in human, one (the electron 
transport chain genes) showed similar age regulation in the other three species (Zahn et 
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al. 2006) Compared to humans, mice age 20 to 30 times faster, flies age 400 times 
faster, and worms age 2000 times faster.  
Given this large difference in life span, it is interesting that there is a similar twofold 
decrease in overall expression of the electron transport chain in each species. 
Expression of the electron transport chain may be a particularly interesting biomarker 
for aging because it scales with life span in species that are distantly related. 
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CHAPTER 3:THE  p21 GENE 
 
3.1 P21 roles and regulation 
 
p21
WAF1/CIP1
 is a cyclin-dependent kinase (cdk) inhibitor, and
 
is a key mediator of p53-
dependent cell cycle arrest after DNA
 
damage (Gartel at al., 1996; Gartel at al., 1998).  
Induction of the cyclin-dependent kinase (CDK) inhibitor p21
Waf1/Cip1/Sdi1
 is a common 
mechanism of growth arrest in different physiological
 
situations.  
p21 is transiently induced in the course of replicative
 
senescence, reversible and 
irreversible forms of damage-induced
 
growth arrest, and terminal differentiation of 
postmitotic cells; as discussed above, 
 
its induction is regulated through p53-dependent 
and -independent
 
mechanisms (Gartel at al., 1996).  
The N-ammino domain is necessary to inhibit cylin/cdk activity  while the ,
 
the C-
terminal portion of p21, associates with the PCNA and can inhibit DNA replication 
directly or inhibits apoptosis through binding procaspase 3 and blocking its processing 
and activation , thus protecting cells against fas induced apoptosis. 
p21 was also reported to bind c-Jun amino-terminal kinases, apoptosis
 
signal-regulating 
kinase 1 and Gadd45 (Gartel at al., 1996, Gartel 2002.).  
 
 
Figure 1: p21 gene rapresentation 
 
Although p21 is not a transcription factor, it is conceivable
 
that some of its functions 
may be mediated by indirect effects
 
of p21 on cellular gene expression. 
 
 
 
 
 
 
(Dotto, 2000) 
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3.2 P21 trascriptional regulation 
 
P21 is a target for diverse signals that induce growth arrest and differentiation.  Its 
expression is usually controlled at the transcriptional level by both p53-dependent and 
independent mechanisms. (reviewed in Gartel and Tyner, 1999) 
 
3.2.1  P53 dependent induction of p21 trascription: p53 tumor suppressor protein is 
required for the transcription of a number of genes involved in growth control. 
While p53 is not required for induction of p21 trascription during development and in 
most tissues of the adult mouse, gamma irradiation of p53 deficient and normal mice 
suggested that p53-dependent regulation of p21 is critical for the response to DNA 
damage (Macleod at al.,genes dev, 1995). 
 
Until last year due to the fact that most analyses of the p21 promoter were restricted to 
the first 3 kb, it has been thought that the p21 promoter contained only two p53 
responsive elements at approximate positions -1400 and -2300.  
Only recently Saramaki et al., identified a novel p53 sites at position -4500 thus 
suggesting that the p21 promoter were bigger than believed so far. 
Their results indicated a 10-fold lower binding affinity of this novel site, compared to 
the site at position -2300. In contrast this novel p53 binding region demonstrated a 
significant induction after 5-fluoracil treatment. 
Since p21 promoter contains high and low affinity sites, it may support a hypothesis 
that affinity dictates the choice between cell cycle arrest and apoptosis, with high 
affinity sites regulating cell cycle arrest and low affinity pro-apoptotic effects (Vousden 
et al., 2002) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: p21 promoter and cis acting binding sites 
 
 
 
 
-4900 -4232 
 
-4500 
New p53 
binding site 
 
(Gartel. Exp, Cell, 
Research 1999) 
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3.2.2   p53 independent regulation of p21 gene expression 
 
A variety of agents that promote differentiation activate p21 trascription by p53 
independent mechanisms. These agents induce binding of different transcription factors 
to specific cis-aciting elements located with the p21 promoter.  
The region between -119 bp and start of transcription of the human p21 gene contains 
six Sp1 binding sites and plays a major role in the regulation of p21 trascription. The 
tumor suppressor protein BRCA1 transactivates p21 in p53 independent fashion via the 
region from -143 to -93 bp which contains the Sp1-1 and Sp1-2 sites. The sp1-3 site in 
the p21 promoter has been shown to be required for p21 induction by transforming 
growth factor –B , Ca, butyrate , lovastatin, the histone deacetylase inhibitor, 
trichostatin A (TSA) and NGF (reviewed in Gartel and Tyner, 1999) 
TGF and butyrate inhibit proliferation and induce G1 cell cycle arrest in various cell 
types, whereas Calcium induces differentiation of cultured keratinocytes.  
The transcriptional coactivators p300 and CBP possess histon acetyl transferase  
activity and interact with other transcription factors to regulate gene expression. 
 
p300/CBP can cooperate with sp1 and/or sp3 to induce expression from the p21 
promoter. Addition of nerve growth factor to PC12 cells induces neuronal 
differentiation and p21 expression.  
         A variety of other transcription factors such as AP2, E2Fs, STATs, C/EBP alfa 
and beta and the homeobox transcription factor gax can induce p21 trascription n 
response to different signals. (see table n.3 ) E2F1 and E2F3 but not E2F4 , strongly 
transactivate p21 transcription through cis-acting elements located between nucleotides 
-119 to +16 of the p21 promoter.  
In addition EGF and IFN induced growth arrest and differentiation in a variety of cell 
lines by increasing levels of p21mRNA but the mechanisms responsible for this 
induction have not been established.  
The hematopoietic growth factor thrombopoietin induces megakaryocytic 
differentiation and trascription activation of p21 by STAT5 trough two STAT binding 
sites.  
    Il6 induced differentiation of an osteoblast-like human osteosarcoma cell line and can 
stimulate activity of a 2.4 kb segment of  the p21 promoter.  
          The hormonal vitamin D activates the p21 and leads to the expression of terminal 
differentiation markers in the myelomonocytic U937 cell line.  
A functional vitamin D3 responsive element has been identified at -771 bp of the p21 
promoter. 
P21 is also transcriptionally activated by retinoic acid in U937 cells and a functional RA 
responsive element was localized between -1212 and -1194 in the p21 promoter.  
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The table n.3 belove summarize the main p53-indipendent activators of p21 
transcription. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table n.3 p53-indipendent activators of p21 transcription.(Gartel et al., 1999) 
 
 
In conclusion a variety of very different extracellular signals can regulate the p21 
promoter, often trough the same transcription factors and cis-acting elements. At the 
same time transmission of a specific extracellular signal may be delivered by a diverse 
set of transcription factors in different cellular environments.  
The p21 promoter appears to represent a unique sensor that is able to integrate many 
extracellular stress signals into cellular decisions that lead to proliferation or cell cycle 
arrest.(Gartel et al., 1999) 
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3.3  p21 and aging 
 
p21 is an intriguing gene integrating stress response mechanisms to aging  
Some evidences suggest that the effects of p21 induction
 
on gene expression in 
senescent cells may contribute to the pathogenesis
 
of cancer and age-related
 
diseases.  
Also p21 up-regulates
 
multiple genes that have been associated not only with 
senescence but also implicated
 
in age-related diseases, including atherosclerosis, 
Alzheimer's
 
disease, amyloidosis, and arthritis thus suggesting  that p21 may play a 
causal role or can be linked to different
 
age-related diseases.(Chang at al., 2001) 
Particularly Chang et al., showed that p21-induced APP gives rise to -amyloid
 
peptide, 
the main component of Alzheimer's amyloid plaques. p21
 
strongly induces the 
inflammatory protein SAA, deposition of which
 
causes amyloidosis and contributes to 
atherosclerosis, osteoarthritis,
 
and rheumatoid arthritis (Jensen, L. E. et al1998). p21 
also induces t-TGase, which
 
has been described as a pleiotropic mediator of cell 
differentiation,
 
carcinogenesis, apoptosis, and aging and which plays a role in
 
plaque 
formation in both Alzheimer's disease and amyloidosis (Dudek, S. M. et al., (1994) Park 
S. et al., 1999) 
p21-induced CTGF and galectin-3 have been implicated in
 
atherosclerosis (Oemar, B. et 
al., 1997 ; Nachtigal, M et al., 1998), whereas p21-up-regulated complement
 
C3 and 
AMP deaminase were suggested to play a role in Alzheimer's
 
disease (Sims, B., et al., 
1998; Howie, A. J., et al., 1985). 
In addition, expression of p21-induced proteins
 
cathepsin B, PAI-1, fibronectin, N-
acetylgalactosamine-6-sulfate
 
sulfatase, and Mac2-BP has been associated with 
osteoarthritis
 
and/or rheumatoid arthritis (Cerinic, M. M., et al., 1998;  Seki, T., et al., 
1998) 
The elucidation of the mechanisms and the specificity of the effects
 
of p21 on gene 
expression may suggest new approaches to the prevention
 
of different diseases that are 
associated with human
 
aging. 
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CHAPTER 4  : longevity 
 
 4.1 Lessons from centenarians  
 
Centenarians can be considered as a  model to address the biological basis of aging 
and longevity. 
One of the main characteristic of centenarians is having a history of aging very slowly 
and either markedly delayed or entirely escaped diseases normally associated with 
aging such as Alzheimer's disease, cancer, stroke and heart disease 
• . survivors‖: diagnosis of age-related disease before age 80, survived it. 24% of 
males, 43% of females. 
•  ―delayers‖: diagnosis of age-related disease after age 80. 
•  44% of males, 42% of females. 
•  ―escapers‖: live to 100 without any age-related disease.  
• 32% of males, 15% of females. 
(Evert et al., 2003) 
Indeed, despite the increasing numbers of very old people, centenarians are very unique 
in the population infact they are still few from a demographic point of view; in 
economically developed countries their number approx. 1 in 5000 to 10 000 of the 
population.  
However, at the same time, centenarians are by definition extremely old people, and 
show all the signs and the characteristics of a prolonged aging process.   
   All the phenotypic characteristics of nonagenarians and centenarians fit the hypothesis 
that aging is a remodeling process where the body of survivors progressively adapts to 
internal and external damaging agents they are exposed to during several decades  
(Capri et al., 2006) 
 
As proposed by Franceschi et al., inflammaging which caracherize aging is explained 
by an imbalance between inflammatory and anti-inflammatory networks, which results 
in the low grade chronic pro-inflammatory status.  
        Within this perspective, healthy aging and longevity are likely the result not only 
of a lower propensity to mount inflammatory responses but also of efficient anti-
inflammatory networks, which in normal aging fail to fully neutralize the inflammatory 
processes consequent to the lifelong antigenic burden and exposure to damaging agents. 
Such a global imbalance can be a major driving force for frailty and common age-
related pathologies. 
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4.2 Genetics of longevity  
 
How much of human longevity is due to genes? Many epidemiological data indicate the 
presence of a stong familiar component of longevity that is largely determined by 
genetics , and a number of possible associations between longevity and allelic variants 
of genes have been described. Estimates of the heritability of human lifespan vary from 
10-50% with the most common finding being that about a third of human lifespan may 
be heritable. Phenotypes that suggest slower aging, such as survival to 90+ years, may 
have an even stronger genetic basis, which explains why centenarians and near-
centenarians tend to cluster in families.  
In the table n.4  belove a brief summary of the major contributions to understand the 
genetics of longevity. The genes and genetic pathways which gave the most important 
insights on longevity are shown for each of the most used animals models and humans. 
Some of those Longevity- genes are inflammation and anti-inflammation genes 
(Franceschi at al., 2005), APOE, ApoPOB (Smith, 2000, De Benedictis at al., 1997), 
Other genes involve other pathways such as the Sirtuin and the insulin one that has been 
also linked to longevity in Yeast and worms. (Rose at al., 2003), IGF1R ( Franceschi at 
al. 2005), Kim at al., 1999, Lin at al., 2001.Also studies on Mithocondrial DNA has 
suggested that mtDNA variants have an impact on the survival in the early stages of life 
as well in attaining extreme longevity. (De Benedictics at al., 1999, Zhang at al., 2003). 
 
 
The tablen.4  highlight the Major contribution to understand the genetics of longevity (from 
Franceschi et al.,) 
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In conclusion, centenarians are an ideal group of people for the study of specific genes 
that are either directly associated with longevity or enable people to escape or delay the 
effects of age-related diseases. 
 
 
Identifying factors that help us remain healthy, vigorous and disability-free at older ages 
is one of our major research priorities. Identifying genes (and variations of those genes) 
that impact human aging and longevity is a promising novel strategy. 
If such genes and their genetic pathways can be identified then novel therapies might be 
created that affect the biology of these pathways.  
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AIMS OF THE WORK  
 
Project #1  
 
Aim : to identify polymorphic variants in the p21 gene and their possible 
involvement in longevity 
 
Induction of cyclin-dependent kinase inhibitor p21(Waf1/Cip1/Sdi1) triggers cell 
growth arrest associated with senescence and damage response.  
It has been proved that p21  also up-regulates multiple genes that have been associated 
with senescence or implicated in age-related diseases, including atherosclerosis, 
Alzheimer's disease, amyloidosis, and arthritis. For example, when the gene APP is 
activated by p21, it produces the beta-amyloid peptide, which forms plaques in the brain 
that are a hallmark of Alzheimer's disease.(Chang et al., 2000) 
 The p21 gene is also linked to the activation of the inflammatory protein SAA, which is 
involved in the development of hardening of the arteries and arthritis according to the 
report published by Chang et al.,  in the April 11, 2000 issue of the Proceedings of the 
National Academy of Sciences.  
 
The main goal of this study consists in the identification of polymorphisms in the p21 
gene that may affect the induction of  the p21 regulated genes involved in age-related 
disease and eventually implicated in longevity and healthy aging.  
Infact centenarians not only exhibit extreme longevity but also have delayed, survived 
or escaped diseases associated with the aging process (such as cardiovascular disease, 
Alzheimer's disease, and some types of cancer). These characteristics make centenarians 
an ideal group of people for the study of specific genes that are either directly 
associated with longevity or enable people to escape or delay the effects of age-related 
diseases. 
 
 
Discovering polymorphisms in the p21 gene  that could impart the ability to live to old 
age while compressing the period of disability toward the end of life yields important 
insight into how the aging process increases susceptibility to diseases associated with 
aging and how this susceptibility might be modulated. 
 
Strategy-Project #1 
 
The study has been structured in 3 main steps:  
 
-Sequence p21 gene (3 exons) and p21 promoter (5 kb) from 10 (european) 
centenarians; identify polymorphisms and their frequencies (Pilot study) 
 
-Compare the frequencies of the polymorphisms identified in the centenarians with the 
known frequencies of the general population reported in NCBI 
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-Use Sequenom to determine the frequency of polymorphisms in ~100 individuals 
in the general population; identify polymorphisms that are present at a lower 
frequency in the general population  
               
 
- (in progress). Verify centenarian-specific difference by using Sequenom to determine 
the frequency of polymorphisms in ~200 centenarians and additional ~200 individuals 
in the general population 
 
-Functional studies : in case I found interesting difference in the frequencies  
The aim of step 4 is to 
-clone the region of interest in a Luciferase plamsid 
- carry out functional studies in order to verify whether the polymorphic variant/s effect 
the activity of the p21 gene. 
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Project #2 
 
Aim: to evaluate the differences in gene expression between centenarians, elderly, 
young in dermal fibroblast cultures and their response to p21 and DNA damage. 
 
Aging is a remodeling process where the body of survivors progressively adapts to 
internal and external damaging agents they are exposed to during several decades.  
This progressive remodeling process which involves a wide range of physiological 
changes and trough, mainly, gene expression changes is associated with a progressive 
functional decline, a gradual deterioration of physiological function, including a 
decrease in fecundity (Partridge and Mangel, 1999). 
Many biological processes involved in aging are shared across diverse species. For 
example, previous studies have lead to postulate that oxidative stress and DNA damage 
play a role in aging and longevity in nearly all animals. 
Some data from Lu et al., have suggested that DNA damage have a role in age related 
changes in gene expression.     Their finding suggested that accelerated DNA damage 
may contribute to reduced gene expression in the human brain after age 40 and that 
DNA damage acts selectively on promoter of the age-downregulated genes .they argue 
that these phenomena may be a potential mechanism whereby the expression of specific 
genes could register the passage of time.      However the mechanims by which DNA 
damage ―select‖ the targeted promoter is but so far the mechanism is poorly understood.  
In addition some experimental evidence suggests that epigenetic changes could also be 
critical determinants of cellular senescence and organismal aging. 
 
The project#2 is focused on the investigation of the relationship between DNA damage 
response and age related changes in gene expression.  
Microarrays analysis were performed on actively dividedly dermal Fibroblasts cultures 
from subject young, elderly and centenarians treated and untreated with the DNA 
damaging agent doxorubicin which in turn acts inducing oxidative stress (thus cell 
senescence) and p21. 
We used the unique materials from centenarians who can be considered as the best 
model of healthy aging. Infact, centenarians are characterized by having a history of 
aging very slowly and either delayed of escaped diseases normally associated with 
aging. 
At the same time, intriguitly enough, centenarians are also by definition extremely old 
people and show all the signs and the characteristics of a prolonged aging  process. 
 
The main aims of project #2 are:  
 to identify  genes showing interesting age correlations  
 to generate a centenarian gene expression “signature” 
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 to evaluate  the effect of aging in the stress response  
 to  highlight the different pathways involved in the stress response in aged 
people and centenarians  
 to correlate stress response in aging with p21 induction  
 
 
the strategy of this project is esemplifiacated belove: 
 
-Microarray analysis of gene expression in 10 cultures from individuals of different 
ages in order to identify genes showing age correlations (pilot study) 
 
-Correlate age-specific difference in gene expression with transcriptional effects of p21. 
To carry out this step we compared the data obtained from the Microarray analysis of 
gene expression from individuals of different ages, with the Microarrays data relative to  
fibroblast WI38 transfected with a lentivirus which induces an ectopic expression of 
p21. 
 
-Determine the effects of DNA damage (which induces p21) on the expression of 
identified genes (trough RQ-PCR ) in independent samples  
 
-to extend the Microarrays studies to a set of fibroblast samples 15 (5 young, 4 old, 5 
>90 y.o subjects) before and upon treatment with the DNA damaging agent  
Doxorubicin (in progress) 
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CHAPTER 5: MATERIALS AND METODS  
 
5.1 Cell Cultures 
Human fibroblasts (coriell bank, Bologna University) cells young, elederly, and > 90 
y.o subjects,  were grown in Eagle's MEM with Earle's salts with  supplemented with 
10% FCS and 2 mM L-glutamine in a humidified 95% air/5% CO2 incubator.  
DFs from 6
th
 to 14
th
 passage were used for all the experiments. 
The DFs were allowed to reach sub confluence prior of being treated to the 
chemioterapic treatment (500 ng/ml doxorubicin). 
Cells were collected after 48 hours of treatment : in order to extract RNA about 3-4 
10^6 cells (before and upon treatments) were washed in PBS, scrapered and collected. 
 
5.2 Samples  
Fibroblasts samples 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
NAME  AGE PROVENIENCE 
C5 17 ITALY-FRANCESCHI 
AG11747 22 CORIELL BANK 
AGO4054 29 CORIELL BANK 
AGO5247 87 CORIELL BANK 
AGO4356 74 CORIELL BANK 
AG11795 76 CORIELL BANK 
C1 63 ITALY-FRANCESCHI 
CENT 3 100 ITALY-FRANCESCHI 
CENT6 100 ITALY-FRANCESCHI 
BELZ 100 ITALY-FRANCESCHI 
AG07124 26 CORIELL BANK 
BER 22 ITALY-FRANCESCHI 
2PRAT 25 ITALY-FRANCESCHI 
AG09975 25 CORIELL BANK 
AG11748 22 CORIELL BANK 
AG4054 29 CORIELL BANK 
AG11735 25 CORIELL BANK 
AG09860 26 CORIELL BANK 
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Fibroblasts samples 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
NAME  AGE PROVENIENCE 
AG11732 24 CORIELL BANK 
AG07356 27 CORIELL BANK 
AG11733 70 CORIELL BANK 
AG11725 84 CORIELL BANK 
AG5247 87 CORIELL BANK 
AG11795 76 CORIELL BANK 
AG4356 74 CORIELL BANK 
AG07720 24 CORIELL BANK 
AG08434 29 CORIELL BANK 
AG09266 26 CORIELL BANK 
AG06310 27 CORIELL BANK 
AG06234 17 CORIELL BANK 
AG07135 77 CORIELL BANK 
AG11488 84 CORIELL BANK 
AG013349 86 CORIELL BANK 
AG04382 81 CORIELL BANK 
AG07801 70 CORIELL BANK 
AG04059 96 CORIELL BANK 
AG09602 92 CORIELL BANK 
AG07725 91 CORIELL BANK 
AG08433 94 CORIELL BANK 
AG12788 90 CORIELL BANK 
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DNA samples 
Coriell Bank: 10 DNA samples (europeans)  (DNA from 5 females and 5 males each of 
whom is over the age of 90) were obtained from the CORIELL bank. The DNA samples 
belong the NIA aging cell repository DNA panel.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DNA –Franceschi Lab:  
~200 DNA from general population (europeans) and ~ 200 from centenarian population 
(europeans)  
 
 
 
 
 
 
 
 
 
AG12257 Male 95 YR 
AG11716 Male 98 YR 
AG11426 Female 101 YR 
AG11398 Female 98 YR 
AG11371 Male 95 YR 
AG11354 Female 97 YR 
AG11340 Female 96 YR 
AG11467 Female 100 YR 
AG14615 Male 93 YR 
AG11400 Male 92 YR 
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5.3 RNA extraction 
 
Total RNA was extracted using the  RNeasy Mini Kit according to manufacture’s 
instructions (Quiagen)  
RNA quality control 
Before submitting RNA samples for labeling and hybridization, the quality was checked 
by : 
1. measuring  the optical density (OD) of total RNA and mRNA samples including 
OD260, OD280, OD260 /OD280 
2. Visualizing each total RNA sample by running on an agarose gel containing 
1.1% formaldehyde  
For each total RNA sample, 12 µg  were sent at a concentration 1 µg/µl. 
The quality of RNA was then double-checked by the Micorarrays facility because to 
obtain high quality data from a gene chip experiment, it is essential to start with high 
quality total RNA.  
Micorarrys facility RNA Quality Control 
Spectrophotometric Analysis: 
A small amount of your sample will be assayed with an Eppendorf BioPhotometer( at 
least 1 mg/mL. ) The OD 260/280 is calculated to estimate the purity of the RNA. A 
ratio close to 2.00 indicates a high percentage of ribonucleotide. 
Electrophoretic Analysis: 
To assess the integrity of your total RNA, the facility tests it with the Agilent 
Technologies 2100 Bioanalyzer Lab-on-a-chip system. This assay is similar to gel 
electrophoresis in concept, but it is cleaner, more efficient, and only requires a very 
small amount of sample. 
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Agilent's Lab-on-a-chip technology 
A small amount of sample is loaded into the wells in the chip and electrodes cause the RNA to move 
through microchannels filled with a sieving polymer and fluorescent dye. Fluorescence signal is plotted 
against run-time to generate an electropherogram or translated to gel-like images. 
5.4 cDNA synthesis 
cDNA synthesis was performed with ~ 2.5 ug of total RNA using Superscript III 
(invitrogen) reverse transcriptase as follows. RNA template was added to 1 ul of RT 
primer (100 uM) Universal RT primer (URT) , 1 ul of dNTP mix (each base 10 uM) and 
DNase /RNase –free water to a colume of 12 ul. The solution was incubated at 65 C for 
5 min and then cooled to 4 C. A master mix containing  4ul of 5X first-strand buffer 
(invitrogen) , 2 ul of 1 mM DTT and 1 uL DNase/RNase-free water per RT sample was 
prepared and added to each sample. The samples were incubated at 25 – 5min folowed 
by 50 – 60 min and finally 70°  for 15 min. 
 
5.5 Real-time quantitative PCR 
In order to verify the behavior of the gene of the signature in an additional set of 
samples , real time PCR was performed using cDNAs prepared from the RNAs of a 
total of 15 of young and old human skin fibroblasts before and upon stress 
(Doxorubicin). 
The experiment was perfomed a 7900 HT sequencer . 
   5.5.1  URT primers strategy   
In order to  assure a specifity of the RQ PCR, the following uRT primers strategy has 
been used. 
      A major confounding problem for standard reverse-trasciption-priming strategies is 
the presence of contaminating genomic DNA (gDNA) carried over from the original 
―RNA‖ extract into the RT and PCR steps. In order to avoid false RNA-Specific PCR 
primer pairs, I followed a new strategy  proposed by Greg Hurteau currently working in 
the Roninson Lab (Hurteau at al., 2002).  
A universal RT primer has been designed that targets the polyA) tail of mRNA and adds 
unique tag sequence not otherwise existing in the human genome.  
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Genomic DNA does not incorporate this RT-inserted unique tag. PCR is then performed 
using a transcript-specific forward primer and a reverse primer that is identical to the 
unique tag incorporated at RT.  
Only cDNA made with this RT primer is compatible with this reverse PCR primer , thus 
eliminating confounding signal from contaminating gDNA. This methos performs 
RNA-specific qualitative and quantitative evaluation of gene expression, while 
preservinf the sensitivity of standart RT-PCR techniques.      
5.5.2 Protocol 
the cDNA templates were added to a mix containing  Buffer 7.5 (Applied 
Biosystems),ul,  Primer (PF+PR) 0.5ul, cDNA  1ul and RNase free water to a volume of 
10 ul. 
PCR cycling conditions were: 40 cycles of 30 s at 95°C, 30 s at 60°C and 30 s at 72°C. 
RQ-PCR primers 
il1-r GTC GGA GAT TCG TAG CTG GAT 
il1-f CTC GCC AGT GAA ATG ATG GCT 
mxr1-f GTT TCC GAA GTG GAC ATC GCA 
mxr1-r GAA GGG CAA CTC CTG ACA GT 
DUSP4-f GAC ATC TGC CTG CTC AAA GG 
DUSP4-r CAC TGC CGA GGT AGA GGA AG 
MBNL2-f GTA CCA GCG CGG TCT TTA AC 
MBNL2-r AGC AGA AAC GGA ATG GAA TG 
earlyendantigen1-f AAG AGG CCA AAC CTG ATG GG 
earlyendantigen1-r GCA ATT TCA GTA GCA AGT TGG G 
utrophin-f                    GCA AGG CTC AAA CTT ATT TGG G 
utrophin-r TCA GGC GCT GTA CTC TGT ATA TT 
radixin-f AAA TCC CAG TAG GCT TTT ACC A 
taok f2 ACT TAG TGA CCA TTT GGC ATC A 
Soares xv 
35c04.x1-f2 GGG AGA TAC CAT GGT TTA ACG TA 
NME5-f CCT CGA AAG AAC AAA TCA TGA AC 
 HIST1H2BD-f CAG ACC TAG TTA CTG GGA ATT CAT 
AU156822-f2 CTG GGT CTT ATA AAA ATC AGG TAC AAA 
lln3-f2 ATT AGG TGA GCT TTA TCC TCC TCT G 
p16-f2 TTC ATG ACA AGC ATT TTG TGA ACT A 
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RQ-PCR primers sequences 
FLJ20637-f TGG ACC AAG TGA CAC AAG CAA 
FLJ20637-r TGG CTA ATT CGG CTT ATT TCT GG 
aldr1-f GGC ATC CTC TGT ACC CCT TT 
sxemidin F2 GGC ATG GGA AGA ATG AAA GA 
Soares-qf93g07.x1 -f GCT GTC TTC CCA AGT TGA CC 
Herc6-f GCC CTG TCT CTC TGT GGG A 
Herc6-r AGA GCG ATT GTC TCC AAA TGT G 
universal AAC GAG ACG ACG ACA GAC TTT 
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5.6 MICROARRAYS 
 
5.6.1 Microarrays: general characteristics  
It is widely believed that thousands of genes and their products (i.e., RNA and proteins) 
in a given living organism function in a complicated and orchestrated way that creates 
the mystery of life. However, traditional methods in molecular biology generally work 
on a "one gene in one experiment" basis, which means that the throughput is very 
limited and the "whole picture" of gene function is hard to obtain. In the past several 
years, DNA microarray, has attracted tremendous interests :this technology promises to 
monitor the whole genome on a single chip allowing to have a better picture of the 
interactions among thousands of genes simultaneously.  With microarray technology, 
the transcription thousands of genes can be determined simultaneously. 
An array is an orderly arrangement of samples. It provides a medium for matching 
known and unknown DNA samples based on base-pairing rules and automating the 
process of identifying the unknowns. An array experiment can make use of common 
assay systems such as microplates or standard blotting membranes, and can be created 
by hand or make use of robotics to deposit the sample. In general, arrays are described 
as macroarrays or microarrays, the difference being the size of the sample spots. 
Macroarrays contain sample spot sizes of about 300 microns or larger and can be easily 
imaged by existing gel and blot scanners. The sample spot sizes in microarray are 
typically less than 200 microns in diameter and these arrays usually contains thousands 
of spots. Microarrays require specialized robotics and imaging equipment that generally 
are not commercially available as a complete system.  
There are two variants of the DNA microarray technology, in terms of the property of 
arrayed DNA sequence with known identity:  
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Format I: probe cDNA (500~5,000 bases long) is immobilized to a solid surface 
such as glass using robot spotting and exposed to a set of targets either 
separately or in a mixture. This method, "traditionally" called DNA microarray, 
is widely considered as developed at Stanford University.  
Format II: an array of oligonucleotide (20~80-mer oligos) or peptide nucleic 
acid (PNA) probes is synthesized either in situ (on-chip) or by conventional 
synthesis followed by on-chip immobilization. The array is exposed to labeled 
sample DNA, hybridized, and the identity/abundance of complementary 
sequences are determined. This method, "historically" called DNA chips, was 
developed at Affymetrix, Inc. , which sells its photolithographically fabricated 
products under the GeneChip® trademark. Many companies are manufacturing 
oligonucleotide based chips using alternative in-situ synthesis or depositioning 
technologies.  
Human Genome U133 Plus 2.0 Array-affimterix 
  In our pilot (project #2) study we use the U133 plus 2.0 array chips which are able to 
complete coverage of the Human Genome for analysis of over 47,000 transcripts  
 
Human Exon 1.0-affimetrix 
We have been using, in the second part of project #2, the GeneChip® Human Exon 1.0 
ST Array that enables two complementary levels of analysis—gene expression and 
alternative splicing.  
Multiple probes per exon enable "exon-level" analysis and allow to distinguish between 
different isoforms of a gene. This exon-level analysis on a whole-genome scale allow us 
to detecting also specific alterations in exon usage that may play a central role in 
disease mechanism and etiology.  
The second level is "gene-level" expression analysis, in which multiple probes on 
different exons are summarized into an expression value of all transcripts from the same 
gene. 
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5.6.2 Software for microarrays analysis: genespring  
 
 the Roninson lab we has  a site license for GeneSpring version 7 
(www.silicongenetics.com). The software allows to visualize, organize and manipulate 
gene expression data. 
Normalization steps can be applied in virtually any order and include operations such as 
dye swapping experiments and median polishing. Scenarios can be saved and applied in 
other experiments. GeneSpring offers visually intuitive filtering tools for both entry-
level and advanced users. All visual filtering windows generate graphs of results in real-
time. These filters allow to exclude particular conditions, set minimum and maximum 
values and choose specific gene lists to filter. The advanced filtering window allows 
you to create complex Boolean expressions to identify genes with a highly specific 
expression pattern.  
It a lso provides various analysis tools, such as t-tests, 2-way ANOVA tests and 1-way 
post-hoc tests for reliably identifying differentially expressed genes. GeneSpring also 
has class prediction tools that can identify genes capable of discriminating between one 
or more experimental parameters or sample phenotypes. Groups of genes identified by 
expression profiling can be further characterized by performing sequence searches for 
potential regulatory elements.  
GeneSpring provides sophisticated clustering methods to uncover patterns of gene 
expression data and the relationships between these patterns. Researchers can use one or 
a combination of clustering options to characterize their data: gene trees (hierarchical 
clustering), experiment trees, self-organizing maps, k-means, Principal Components 
Analysis (PCA) and QT clustering. QT clustering is an unsupervised technique that 
allows you to specify both the minimum size and maximum correlation coefficient of 
each cluster. Principal Components Analysis (PCA), allow s you to reduce the 
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complexity of your data by discovering a number of principal components that define 
most of the data variability. Pathways may also be explored with the pathway viewer, 
genes and their expression patterns can be visually characterized based on their location 
within a cellular pathway.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 35 
  5.7 P21-PCR-SEQUENCING 
5.7.1 Sequencing: generality 
There are several methods available to determine the actual sequence of nucleotides 
in a segment of DNA.  One  procedure uses specially altered nucleotides called 
dideoxynucloetides which have been made either radioactive or fluorescent. 
For sequencing the p21 promoter, I used the PCR-SEQUENCING strategy: when 
enough of the targeted DNA fragment has been amplified by PCR, the mix is put 
through a series of DNA sequencing reactions that are a variation of PCR.   
A 3 ul of mix ontaining Taq DNA polymerase, and all four of the nucleotide bases 
(A, T, C, G.) was added to 1ul of  primer that can hybridize at the desired location on 
only one complementary strand of the DNA (as opposed to both strands in PCR),  to 
1 ul of  the amplified product from the PCR  and water up to 10 ul total final volume. 
In addition, small amounts of fluorescence labeled dideoxynucleotides (A, T, C, G) 
are added to the mixture.  Dideoxynucleotides are human-made nucleotides whose 
sugar component is slightly different from that of the nucleotides that make up 
DNA.  (There is no OH on the 3' carbon.) Dideoxynucleotides can be picked up and 
added to a growing DNA chain.  However, as a result of this structural difference 
another nucleotide cannot be added at its 3' end.  Consequently, if one of the 
dideoxynucleotides is added to a growing chain of nucleotides, the strand will be 
terminated.  Each dideoxynucleotide is labeled with a different fluorescent 
compound so that it will give off an identifying color in a laser beam. 
After 20 - 30 cycles of the PCR heating and cooling, the resulting mixture will contain 
a series of fragments of different lengths depending on how many bases had been 
added to the chain before one of the dideoxynucleotides sneaked in and blocked 
further growth. 
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The mix of billions of short fragments from the sequencing reactions is loaded into 
glass capillary tubes that contain a gel solution that serves as a sieving matrix 
During electrophoresis, a voltage is created across the gel so that one end is made 
positive and the other negative.  Since DNA is slightly negative, its fragments will 
move to the positive end of the gel.  Not surprisingly, the different length DNA strands 
migrate at different rates and therefore separate from each other according to size.  The 
smallest strand travels the fastest. 
  
As each DNA fragment reaches the bottom of the capillary tube, its fluorescence-
labeled end dideoxynucleotide is excited by a laser beam that is directed at the bottom 
of the tube 
Each of the four dideoxynucleotides fluoresces a different color when illuminated by 
a laser beam.  An automatic scanner records each wavelength of light and a computer 
generates an electropheorgram with colored peaks representing each wavelength in 
the sequence it passes through the beam.    
3730 DNA Analyzer 
 
For our sequencing I have been using the 3730 DNA analyzer , which is the Gold 
Standard in medium-to-high throughput genetic analysis.  
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5.7.2 PCR SEQUENCING on the p21 gene 
The p21 gene consists in 3 exons (68, 450, 1600 bp) and a 5 kb promoter. 
In order to sequence the whole gene , the exons and the promoter were amplified in 
overlapping fragments. 
Primers design for PCR sequencing 
 A protocol of PCR each amplifying ~ 400 bp of the p21 gene was optimized with the 
following primer pairs (where p21pro.1 represents the farer from the transcription site) 
  Primers were designed using the primer 3 software available on 
http://frodo.wi.mit.edu/. The products size was set to ~400 bp, the primers were sized 
between 22-24 bases with a Tm of 69-71 and a GC content of 40-60 %. The primers 
were checked for loops, hairpins and 3’ complementarity. The best primers pair was 
ordered from idtDNA. 
Once amplified, the fragments were purified with Zymo columns (Zymo research) and 
then sequenced.  
PCRs protocol 
The DNA templates were added to a master mix containing 2ul of each  primer (10 
uM), 5 ul Buffer (New England biolabs) , 2 ul od Taq (), and water to a volume of 50 ul. 
the following PCR profile was used: preincubation for 2 min at 96°C, 40 cycles of 30 s 
at 95°C, 30 s at a primer-specific annealing temperature (see table belove) and 15 s at 
72°C and one final incubation for 5 min at 72°C.  
Name                                          Sequence                                                                                     Tm 
p21.exon1.R AAGGCGAGCTCCCAGAAC 60° 
p21seq.exon1.F ACTGGGGGAGGAGGGAAGT 
p21seq.exon2.F ACCAGCTGGAAGGAGTGAGA 60° 
p21seq.exon2.R  GTCTTTGCTGCCTACTTGC        
p21seq.exon3.F1 TGCGGTGATGGATAAAATCA 58° 
p21seq.exon3.R1 GAAAAGGAGAACACGGGATG 
p21seq.exon3.F2 TCCTAAGAGTGCTGGGCATT 60° 
p21seq.exon3.R2 GCCCTTCTTCTTGTGTGTCC 
p21seq.exon3.F3 TCTTCTCCAGCTGGGCTCT 58° 
p21seq.exon3.R3 CCCAAAAGCCCATTTATTTG 
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Name                                                Sequence                                                                                                      Tm 
p21pro1.r GGGGCTGCCTATGTAGTGAA  58° + 
dmso p21pro1.F.new GTGCCACAGTTCACAAGTGC 
p21pro2.f TTTGCTTCTGGGCAGAACTT 58° 
p21pro2.r CAGAGCCAGGATGAATTGGT                      
P21.pro.3.f GATGTT GTT AGA GCC AGG AAC AG    54° 
P21.pro.3.r ATC AAG GCA TAA AAA TTT CAT TGTG 
P21pro4f                                                      
 
AAA AGG TTT TTG AAT GAA TGG ATG 58.5° 
+dmso 
P21pro4r.new                                                 AGA AGA GGC GGA ACA AAG ATA GAA 
 
P21pro5f.                                                       
 
CAC GCC CGG CCA GTA TAT ATT TTT     58 °+ 
dmso 
P21pro5r.                                                   GAC AAA ATA GCC ACC AGC CTC TTC T 
p21pro6.f CACCTTTCACCATTCCCCTA 58° 
p21pro6.r AGGGCTGGTTGTCAAATGTC 
p21pro7.f TGCATGGTTGCAAACTTTTT 54° 
p21pro7.r TCACCTTTGCCTCCTTTCTG 
p21pro8.f AGGTCAGCTGCGTTAGAGGA 58° 
p21pro8.r GGAAGGAGGGAATTGGAGAG 
p21pro9.f GGAGGCAAAAGTCCTGTGTT 54° 
p21pro9.r ACATTTCCCCACGAAGTGAG 
p21pro10.f TCTAGGTGCTCCAGGTGCTT 58° +dmso 
p21pro10.r CTGTGAACGCAGCACACAC 
p21pro11.f CCGAAGTCAGTTCCTTGTGG 54° 
p21pro11.r GCTTCCTTGGGAACAAACTG 
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5.8 CONSTRUCTS 
5.8.1 pGL4 Reporter Vectors: Description  
The p21 centenarian haplotype area was cloned in a p21-Luc vector (p21-pgl4.10-Luc2 
containing the general population-haplotype and gently provided by A. saramaki) .  The 
pGL4 Vectors are state-of-the-art Luciferase Reporter Vectors. This vector family 
features codon optimized synthetic genes with or without Rapid Response™ 
technology, and clean backbones with dramatically reduced numbers of cryptic 
regulatory elements.  
 
pGL4.10[luc2] Vector sequence reference points: 
Base pairs                                              4242 
Multiple cloning region                                 1-70 
luc2 reporter gene                                      100-1752 
SV40 late poly(A) region                                1787-2008  
Reporter Vector primer 4 (RVprimer4) binding region     2076-2095 
ColE1-derived plasmid replication origin                2333 
Synthetic Beta-lactamase (Ampr) coding region           3124-3984 
Synthetic poly(A) signal/transcriptional pause site     4089-4242 
Reporter Vector primer 3 (RVprimer3) binding region     4191-4210 
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5.9 Cloning of the p21 promoter centenarian haplotype region in a  
P21-PGL4.10 vector 
 
5.9. 1  HAPLO- p21 promoter PCR 
The p21 centenarian-haplotype area of the promoter was amplified  by PCR from 
human genomic DNA (containing the centenarian haplotyphe ) previously sequenced 
and fused with the  p21 PGL.4 Luc (plasmid containing the 5 kb promoter with the 
normal population haplotype and a luciferase reporter gene). 
In order to increase the specificity of the PCR a double round of PCR was carried out 
using  a high proofreading polymerase (New England Biolabs) 
The Phusion DNA Polymerase used in order to limitate the introduction of possible 
errors, generates templates with an accuracy and speed previously unattainable with a 
single enzyme. The unique structure and characteristics of this polymerase make 
Phusion DNA Polymerase a superior choice for cloning, and sets a new standard for 
PCR performance: its error rate is 50-fold lower than that of Thermus aquaticus, and 
6-fold lower than that of Pyrococcus furiosus - making it the most accurate of 
available thermostable polymerases. Phusion DNA Polymerase possesses processivity 
10-fold greater than Pyrococcus furiosus and twice that of Thermus aquaticus. 
 
The primed template was pre-formed in the presence of 5x  Phusion GC buffer (New 
England Biolabs)  and 200 µM of each dNTPs , 0,5 uM primers , 3% dmso ,1 U of 
Phusion DNA polymerase and water to a final volume of  20 ul. 
Being the template GC rich the dmso was added in order to optimize the product yield 
The sample were incubated as following:  
preincubation for 30 sec at 98°C, 30 cycles of 10 s at 98°C, 30 s at 66°C and 3 min at 
72°C and one final incubation for 5 min at 72°C. 
 
p21-4997F TAC AAA CAT TGG GTG GGG CGA GTC 
p21-R-44 CTC CGG CTC CAC AAG GAA CTG ACT T 
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HAPLO- p21 promoter PCR (PCR product about 2.1 Kb) 
 
The 5kb PCR product of the p21 promoter amplification was used as a template for the 
following PCR (same condition as above)  
 
p21-4497F TAC AAA CAT TGG GTG GGG CGA GTC 
p21-5R GAC AAA ATA GCC ACC AGC CTC TTC T 
 
 
DNA DIGESTION and GEL PURIFICATION 
 
The p21 cent-HAPLO DNA and the plasmid pGL4.10 were digested  O/N at 37 using 
the enzyme AatII/Sph (New England Biolabs) 
The AatII/ Sph enzymes cut  about 2.1 kb of  the pGL4.10 in the haplotype area (where 
we will ligate the cent-haplotype one) ~600 bp in the p21-cent-Haplo PCR product  
 
GEL PURIFICATION  
The product of digestion was run on a gel (1 %) and the  bands of interest (7.142 kb for 
the p21-PGL4.10 and 2.1 for the p21-cent-haplopromoter) were cut and purified using 
the quiagen kit according to the manufacturer’s protocol. 
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5.9.2 LIGATION 
 
The ligation was performed O/N at 37. a mix containing of  Buffer 10X  (New England 
Biolabs) , 1 ul of ligase (New Englad Biolabs) was added at ~50-100 ng of  vector and 
insert. 
The ligation was performed using two different ration vector: insert (1:3, 1:5) in order 
to Increase the chance of ligation.  
The calculation was performed using the promega calculator available at the 
http://www.promega.com/biomath/ , based on the assumption that  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
length of insert (in kb) 
  x  ng of vector  =  ng of insert needed for a 1:1 ratio  
length of vector (in kb) 
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5.9.3 BACTERIAL TRANSFORMATION 
 
Transformation is a technique to introduce DNA into bacterial cells. For cells to uptake 
exogenour DNA they must first be made permeable tso the DNA can enter the cells. 
Some bacteria (i.e. Coli) became competente due to environmental stresses.  
Some of those are treatments with chloride salts of metal cations such as calcium, 
rubidium or magnesium and cold treatment. These changese affect the structure and 
permeability of the cells wall and membrano so that DNA can pass through.  
In my case I used an HEAT shock treatment on E.Coli.  
E.coli bacteria are normally poisoned by the antbiotic ampicillin. Amipicillin acts to 
damage the membranes of e. coli by inhibiting the crosslinking of the bacterial 
membrane. This results in bacteria shich are very structurally weak. The plasmid has an 
additional gene that codes for a B lactamase that is excreted by cells and in a local area 
will hydrolyze ampicillin. Therefore by adding ampicillin, only bacteria that contain the 
plasmid will survive.  
Bacterial Transformation 
The first step of bacterial transformation consist in adding 1-10 l of the DNA 
(Experimental reaction or positive/negative control) to a vial (20-200 l) of competent E. 
coli cells (Invitrogen) and then mix gently.  
The step is followed by an  Incubation on ice for 30 min. then the cells are Heat shock 
for 30 sec at 42˘C  
After heat shock, the cells are Immediately transfer the tubes to ice and incubate for 2 
min then 100 ul of nutrient broth are added. (room temperature). 
This step is followed by shaking  the tubes at 37˘C for 60 min.  
Finally the cells are Spread 50-500 l from each transformation on a L-broth agar plates 
containing antibiotics at the appropriate concentration (AMP) . 
The plates are then overnight at 37˘C.. 
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5.10 Transfections and luciferase reporter gene assays 
 
Luciferases are the most commonly used genetic reporters because luciferase activity 
assays have broad dynamic range and high sensitivity. This makes them ideal for 
processing many samples without the need to test multiple sample dilutions or to 
prepare large quantities of cells.  For vector normalization, activity of two luciferases, 
firefly and Renilla, can be measured in the same lysate  . The internal vector control 
(Renilla)(Promega) must encode a reporter other than that used in the test construct. As 
common,  I used the firefly luciferase as the test reporter and Renilla luciferase as the 
control reporter . 
 
5.10. 1   Transient Transfection-Fugene 6 
Fugene 6 Transfection Reagent (Roche)  is a nonliposomal, multi-component reagent that 
forms a complex with DNA, then transports it into animal cells. 
Compared to other transfection methods, FuGENE 6 Transfection Reagent gives more consistent results, 
saves time and effort, and has minimal effect on cell physiology. 
HCT116 cells plated in a 12 well-  plate the night before to give 60-80% confluence in a 
phenol red-free DMEM. In order to normalize the firefly signal , I carried out a co-
trasfection with the internal vector (a ratio of 10:1 test vector:control vector is used) 
1)47μl of serum-free medium and add 3μl of FuGENE 6 (Roche) directly into the tubes 
with out allowing contact with the walls of the plastic tubes. 
2)A co-trasfection was carried out adding  a total 1µg experimental DNA (Cent p21-
Luc or Normal-p21Luc plus Renilla-Vector)  into the sterile tube, tap the tube or vortex 
for one second to mix the contents. 
3) Incubate the transfection reagent:DNA complex for minimum of 15 min at room 
temperature. 
4) add this mixture directly to the cells drop wise through the medium. Making sure to 
do not evenly sprinkle the droplet over the entire area. There is no need to remove and 
replace with fresh medium. 
5)Incubate for 48 h.  
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5.10.2  Preparation of Cell Lysate for Luciferase assay 
For the preparation I have been using the following protocol: 
1. Remove growth medium from cultured cells. 
2. Rinse cells in 1x PBS. Do not dislodge cells. Remove as much of the final wash as 
possible. 
3. Dispense a minimal volume of 1x lysis reagent (RLB; Promega) into each culture 
vessel  
4. scrape attached cells from the dish, and transfer the cells and solution to a micro 
centrifuge tube. 
5. Pellet debris by brief centrifugation, and transfer the supernatant to a new tube. 
6. Mix 20-30 μl of cell lysate with same volume l of Luciferase Assay Reagent (first 
Dual-Glo™ and then Stop solution-see above) (Promega)  
The Dual-Glo™ Luciferase Reagent can be added directly to cells in growth medium 
without washing or preconditioning. This reagent induces cell lysis and acts as a 
substrate for firefly luciferase, producing a stable luminescent signal that can be read 
over a period of two hours, with >60% of the luminescent signal retained. Addition of 
Dual-Glo™ Stop & Glo® Reagent quenches the luminescence from the firefly reaction 
by at least 10,000-fold and provides a substrate for Renilla luciferase in a reaction that 
can also be read within 2 hours (with similar signal retention).   
Each sample is normalized by dividing the test reporter activity by the control reporter 
activity. Triplicate samples are then averaged . 
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5.11 SEQUENOM 
 
The Company's proprietary MassARRAY® system is a high-performance DNA 
analysis platform that efficiently and precisely measures the amount of genetic target 
material and variations therein. The system is able to deliver reliable and specific data 
from complex biological samples and from genetic target material that is only available 
in trace amounts.  
Sequenom's MassARRAY technology is used to perform allele specific primer 
extension reactions which allow differentiation of homozygous normal, 
heterozygous mutant and homozygous mutant samples (hME assay).  The 
MassEXTEND primer anneals up to the polymorphic site and is extended 
dependent on the polymorphism. The allele products consist of either a one or two 
base extension and their masses are easily distinguished on the mass spectrometer. 
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CHAPTER 6:  HAPLOTYPE ANALYSIS 
 
 
Haplotype Analysis 
 
The haplotype analysis has been performed with two different methods: 
 
1) a EM method (Estimated Maximum likelihood), implemented in Haploview, to 
calculate pairwise linkage disequilibrium (i.e. the association between markers) and 
then to build the LD blocks and estimate the phase from unrelated individuals (Barrett 
et al., 2005). 
The default algorithm is taken from Gabriel et al, Science, 2002. 95% confidence 
bounds on D prime are generated and each comparison is called "strong LD", 
"inconclusive" or "strong recombination". A block is created if 95% of informative 
(i.e. non-inconclusive) comparisons are "strong LD". This method by default ignores 
markers with MAF < 0.05. The default behavior is to sort the list of all possible blocks 
and start with the largest and keep adding blocks as long as they don’t overlap with an 
already declared block. 
 
To the identified haplotypes, a chi-square similar statistics is applied to compare 
estimated haplotype frequencies in cases versus controls. 
Even to this results, a permutation test can be applied to correct the obtained p-values 
for multiple testing. 
 
2) another two-stage method, implemented in the WHAP software. 
The primary test is a regression-based analysis of association of haplotype and  trait 
(quantitative or qualitative) with one regression coefficient per haplotype (Sham et al., 
2004).  
The secondary test analyses the relationship between  haplotype  similarity and  
regression coefficient similarity. 
The secondary test is implemented as a multivariate weighted least squares regression 
of effect similarity on genetic similarity. An empirical significance value can be 
combined with the primary omnibus significance value, by Fisher’s method of log-
transformation. 
In each case permutation testing can be applied to generate empirical significance 
values. 
The unit of analysis can be a window/block, or a specific haplotype, so the analysis 
can be done using sliding windows, i.e. testing all possible haplotypes of a certain size 
(irrespectively of the blocks calculation), or testing directly certain haplotypes 
highlighted with the Haploview softare. 
 
 48 
This second approach is very useful since it is possible to combine together the results 
of the primary omnibus test together with the secondary local test which is able to add 
positional information and increase power. 
 
 
LD structure 
 
The Haploview software allows also to build a graphical nice view of the LD structure 
of the population, in order to identify visually the block definition. 
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CHAPTER 7: RESULTS PROJECT #1 
 
 
7.1 Identification of polymorphic variants in the p21 gene and 
promoter regions. 
 
The sequencing was performed first on the 3 exons of the p21 gene which are 
respectively  68, 450, 1600 bp. 
Then I sequenced the whole p21 promoter which is approximately 5 kb. So far only  
2.5 kb of the p21 promoter has been extensively studied. 
 
 
7.1.1 Sequencing of the 3 exons: identification of a polymorphic variant 
in the exon 2 region. 
 
 A transition A->C  at codon codon 31 which leads to Arg-> Ser 
The polymorphic variant has been already charactherzed.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1:  example of Sequence , exon 2, heterogosis A/C 
The frequencies of the polymorphic variant has been reported in NCBI : 
 Average Allele Frequency in the general population: 
                                              A; 0.261 
                                              C; 0.739  
Frequencies in the centenarian population A: 0.28 
                                                                     C:0.71 
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7.1.2 P21 promoter sequencing: identification of  29 polimorphic 
variants  
 
The sequencing of the p21 promoter lead to the identification of 29 polimorphic 
variants. 
up to 29 polimorphic variants(see tables pages): 
-6 polymorphic variants were uncaractherized 
-23 previously charachterized  
                             up ot the 23 already charactherized only 6 had known 
frequencies(reported in NCBI) 
 
Figure 2: Examples of polymorphic variants identified in the p21 promoter of 
centenarians:  
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Figure 3: : Examples of polymorphic variants identified in the p21 promoter of  
centenarians: 
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Figure 4 : Examples of polymorphic variants identified in the p21 promoter of 
centenarians: 
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Figure 5 : Examples of polymorphic variants identified in the p21 promoter of 
centenarians: 
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 Figure 6 Examples of polymorphic variants identified in the p21 promoter of 
centenarians: 
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Figure 7 Examples of polymorphic variants identified in the p21 promoter of 
centenarians: 
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 Analisys on NCBI:  
 
Known RS and frequencies (reported on NCBI) othe the 29 polimorphic variants . 
As  up to 29 polimorphic variants: 
-6 polymorphic variants were uncaractherized 
-23 previously charachterized  
                             up ot the 23 already charactherized only 6 had known frequencies 
 
                                          SNP#         rs 
1 rs=4711458 
2 rs=4711459 
3 rs=4711461 
4 rs=4714002 
5 rs=471146 
6 rs4714003 
7 N.A. 
8 rs=10947623 
9 rs=12192827 
10 rs=12192877 
11 N.A. 
12 N.A. 
13 N.A. 
14 N.A. 
15 rs=4135234                                         
16 rs=3829963      
17 rs=3829964 
18 rs =3829965 
19 rs=4135235 
20 rs=4135237 
21 rs=3829966 
22 rs=3829967 
23 rs=3829968 
24 rs=733590 
25 rs=2395655 
26 rs=2395655 
27 rs=4151702 
28 rs=4135239 
29 N.A. 
 
 
Table 1 List on SNPs and corrispondent Rs (when known) 
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7.2 Comparison of the frequencies of the polymorphic 
variants : Centenarians versus General Population  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
               Table.2 The table belove shows the frequencies of the firs 15 polymorphic variants obtained by 
sequencing the DNA from centenarian subject and trough Sequenom analysis of  DNA from general 
population subjects. 
In addition on the left side, are reported the locations of each SNPs and the CIS ACTING elements close 
to each one (accordingly to Gartel et al., 1999 review). The comparison of the frequencies highlight a 
potential significant difference in the first 10 SNPs of the list which belong an HAPLOYPE where for 
Haplotype is meant a combination of alleles at multiple linked loci that are transmitted together.  
 
 
 
 
 
                                                                                 
1 C :0.874        T:0.115 
 T : O,876,    C:  0,115   T: 0,75         C:0,25 2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
  C: 0,9          T: 0.098 C:0,75           T: 0,25 
 T: 0,885        G: 0,105 T: 0,75          G: 0,25 
A; 0,904        G; 0,095 
A;0,75           G; 0,25 
C; 0,85         T; 0,1185 C; 0,725           T; 0,25  
NA C; 0,75           T; 0,25 
  G; O,85    A; 0,1185 G; 0,77         A; 0,22 
C; O,87    T;0,122 C; 0,71          T; 0,27 
C; 0,91    T ; 0,08 
C; 0,75           A; 0,25 
A; 0,92    G; 0,07 A; 0,9             G; 0,1 
NA A; 0,75            G; 0,25 
G;1 G;0,88            A;0,11 
NA C;0,88            T;0,11 
G;0,92     A;0,07  G;0,875           A;0.125 
C;0,75          T; 0,25  -4568 
-4485 
 
-4341 
 
-4322 
 
-4318 
 
-4248 
 
-4106 
 
-3673 
 
-3538 
 
-3510 
 
 
-3431 
 
 
-3285 
-3009 
 
-2752 
 
-2286 
-4500 
-4232 
-2557 
-2301 
P53 binding site  
STAt 1,3,5 
STAt 1,3,5 
P53, p73 
SNP#       GENERAL POPULATION         CENTENARIANS          
                    SNP POSITION    CIS ACTING ELEMENTS 
H
A 
P 
L
O
T
Y 
P 
E 
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Table.3 The table belove shows the frequencies of the last 29 polymorphic variants obtained by 
sequencing the DNA from centenarian subject and trough Sequenom analysis of  DNA from general 
population subjects.In addition on the left side, are reported the locations of each SNPs and the CIS 
ACTING elements close to each one (accordingly to Gartel et al., 1999 review). 
 
 
 
 
 
 
 
                                                                                 
          C; 0,88        A; 0,105             C; O,71        A0,27             
17          T:0,50          C:0,40              T; 0,55          C;0,45 
 18        A;0,785        G; 0,215 A; 0,71 G;0,27
19                A 1                            A;0,75            T; 0,25 
20         G;0,92           T;0,07               G; 0,92            T ; 0,07 
21         C;0,96           T; 0,1                T;0,92            C; 0,07 
22 
23                 A;1                            A; 0,93          G;0,06 
 24         T; 0,7             C;0,29        T;0,68          C;0,31 
 
25         A;0,665          G; 0,325       A;0,71          G;0,27 
26         G;0,805          C;0,195     G;0,88         C;0,11 
T; 0,92           C;0,07              T;0,92          C; 0,07 
27         G;0,798            C;0,2       G;0,88          C;0,11 
28                  NA                           G;0,875       C;0,125 
29                NA                                        +cc  1 
 -2122 
 
-2009 
 
-1997 
 
-1935 
 
-1613 
 
-1552 
 
-1545 
 
-1482 
 
 
 
-807 
 
-535 
 
-515 
 
-150 
 
-75 
 
 
 
 
 
 
 
 
 
 
 
 
SP1,SP3 
-592          stat1,2,3, 
-771            vitamin d 
receptor 
-1203              RAR 
-1309 -1263              C/EBP 
 
-1394         P53,P73 
-1924           C/EBP 
SNP#             GENERAL POPULATION            CENTENARIANS SNP POSITION KNOWN CIS ACTING ELEMENTS 
16  
 59 
Ratio of the frequencies of the identified polymorphic 
variants 
 
 
 
        SNPs#  1       2        3        4        5        6       7      8        9       10      11   12     13    14   15 
 
 
1.16 1.17 1.20 1.18 1.21 1.13 
 
NA 1.10 1.23 1.21 1.02 NA 1.14 1.07 1.05 
2.17 2.17 2.55 2.38 2.63 2.11 NA 1.86 2.21 3.13 1.43 NA / 0.93 1.79 
 
 
                       16     17       18       19     20    21    22      23     24     25    26     27    28  29 
1.25 1.05 1.11 1.33 1.00 1.05 1.00 1.07 1.02 0.94 0.91 0.91 
2.57 1.13 1.26 / 1.00 0.65 1.00   / 1.08 0.83 0.56 0.55 
 
 
 
UnCommon allele 
 
coommon allele 
 
 
 
Table 4 The table belove shows the ratio between General population and Centenarian 
and Centenarian to General population for the respective frequencies of each allele. 
The ratio highlights a potential significative difference in the SNPs belonging the 
Haplotype (SNPs#1 to SNP#10).  The SNP#16 may be potentially interesting. 
 
HAPLOTYPE  and frequencies 
 
The existence of the haplotype has been validated trough bioinformatic analisys (see 
Materials and Metods- SNP alleles and genotypes statistic) 
 
The  frequencies of the haplotype carriers (almost all in etherozigoses) are: 
5 among 10 centenarians (50%) 
21 among 92 people in general population (23%) 
 P<0.158 (t-test) 
 
GP/Cent 
 
Cent/GP 
SNPs#
GP/Cent 
 
Cent/GP 
NA NA 
 
NA NA 
 
 
 60 
             7.3  Sequenom analysis on adjuntive DNA samples 
 
The siginificance of haplotype representation is being verified by using Sequenom to 
determine the frequency of polymorphisms in ~200 centenarians and additional ~200 
individuals in the general population.  a P< 0.158 (t-test) is indicative of a trend. 
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7.4 Functional studies on the p21 promoter haplotype 
 
 
7.4.1 Cloning of the promoter region containing the haplotype 
 
 
 
 
 
 
 
Luciferase assays 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Luciferase Assays carried out on HCT116 cells (p53 WT or KO) 
transiently transfected with p21-N and p21- 
Figure 8: Sequence of the two cloned plasmid: Sequence of a region of the  of the 
haplotype   showing the two different allelels variants, the one more common in the 
Normal population (p21-Norm) (bottom) and the one more common in the centenarians 
one (p21-Cent)  
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7.4.2  Luciferase assays carried out on cells HCT116  (p53 WT 
and p53 null) transfected with p21-N and p21-C 
 
 
 
 
 
 
 
Figure 9:  Luciferase assays were carried out on cells HCT116  (p53 WT and p53 null) 
transiently transfected with p21-Luc plasmids containing the 2 haplotype variants, p21 
N (common population haplotype) and p21-C (centenarian population haplotype) . 
Initial assays carried out with a single preparation of the common (p21N) and 
centenarian (p21C) promoter haplotypes, shows that both promoter alleles were 2-fold 
more active in the presence of p53: no difference in p53 response 
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Luciferase Assays carried out on HCT116 cells (p53 WT or KO) 
transiently transfected with p21-N and p21-C 
 
 
 
Figure 10: Luciferase assays carried out on cells HCT116  (p53 WT and p53 null) 
transiently transfected with p21-Luc plasmids containing the 2 haplotype variants, p21 
N (common population haplotype) and p21-C (centenarian population haplotype) . 
The initial assay suggested ~2-fold decrease in the basal promoter activity in the 
centenarian haplotype 
 
Quality of plasmid used for the transfection  
 
 
 
 
 
 
 
 
 
Figure 11: Analysis of the quality of the two plamid preparations run on an 
electroforesis gel  showed that the two plasmids have similar quality  
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Luciferase Assays carried out on HCT116 cells (p53 WT or KO) 
transiently transfected with p21-N and p21-C in three indipendent 
DNA preparations 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Luciferase assays carried out on cells HCT116  (p53 WT and p53 null) 
transiently transfected with three indipendent DNA preparation of p21-Luc plasmids 
containing the 2 haplotype variants, p21 N (common population haplotype) and p21-C 
(centenarian population haplotype) . 
The three independent DNA preparations did not confirm the originally observed 
difference in basal promoter levels. 
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CHAPTER 8: RESULTS PROJECT #2 
 
 
8.1.1 Microarrays analysis on changes in gene expression in aging: 
elaboration of a Centenarian-gene signature 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: Identification of  genes showing age correlations performed using the 
program GeneSpring. 
 The ..Microarray analysis of gene expression in 10 cultures from individuals of 
different ages, yields a tentative ―centenarian signature‖: Identified 29 genes that show 
higher expression (>2X)  in centenarians relative to old people and 10 genes that show 
lower expression (<2X)  in centenarians versus old. 
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8.1.2 List of the centenarian signature-genes 
 
 
 Genes up regulated in the centenarians versus old people 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Systematic Common Gene Symbol UniGene 
233011_at ANXA1 
 
Hs.494173 
209840_s_at LRRN3  Hs.3781 
204014_at 
DUSP4; TYP; 
HVH2; MKP2; 
MKP-2 DUSP4 Hs.417962 
209841_s_at 
DKFZp761K2424; 
NLRR3; NLRR-3; 
FLJ11129; 
LRRN3 LRRN3 Hs.3781 
201743_at CD14 CD14 Hs.163867 
230967_s_at USP7  Hs.386939 
214265_at ITGA8  Hs.171311 
220694_at HSPC054   
232925_at    
222167_at PVRL3  Hs.293917 
230970_at SSH2  Hs.335205 
219352_at HERC6;FLJ20637 HERC6 Hs.529317 
1564378_a_at EXT1  Hs.492618 
228635_at PCDH10  Hs.192859 
1559249_at ATXN1  Hs.434961 
241970_at PVRL3  Hs.293917 
206197_at 
NME5; NM23H5; 
NM23-H5 NME5 Hs.519602 
237459_at PCTK2  Hs.506415 
215330_at FLJ43663  Hs.150556 
209911_x_at 
HIST1H2BD; 
H2B/b; H2BFB; 
H2B.1B; HIRIP2; 
MGC90432; 
dJ221C16.6 HIST1H2BD Hs.130853 
202086_at 
MX1; MxA; IFI78; 
IFI-78K MX1 Hs.517307 
230206_at DOCK5  Hs.195403 
236798_at   Hs.551751 
215992_s_at 
DKFZp586O1422; 
RA-GEF;  RAPGEF2 Hs.373588 
39402_at  IL1B                         Hs.126256 
220898_at    
228275_at   Hs.551751 
201272_at 
AKR1B1; AR; 
ADR;  AKR1B1 Hs.521212 
243788_at PHF11  Hs.369039 
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 Genes down regulated in the centenarians versus old people 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Systematic Common Gene Symbol UniGene 
213023_at UTRN; DRP; DMDL; DRP1; FLJ23678 UTRN Hs.133135 
205018_s_at MBNL2   Hs.372571 
204841_s_at EEA1; ZFYVE2 EEA1 Hs.567367 
238420_at TAOK1  Hs.399763 
1552717_s_at KAB  Hs.433891 
204969_s_at RDX RDX Hs.263671 
225575_at LIFR  Hs.133421 
204864_s_at IL6ST; CD130; GP130; IL6R-beta;  IL6ST Hs.532082 
229487_at EBF  Hs.573143 
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8.2 Correlation of  age-specific difference in gene expression 
with transcriptional effects of p21 
 
 
8.2.1 The centenarian  signature in the p21 (Wi38) model 
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 Figure 14: Microarrays analysis has been performed in cells WI38 where the ectopic expression 
of p21 has been obtained by  transfecting those cells with a p21 lentivirus vector. 
The image above show the behavior of the the genes comprising this signature in the p21 WI38 
model : a subset of genes upregulated in centenarians is induced by p21 and a subset of genes 
downregulated in centenarians is inhibited by p21. 
 
a subset of genes that were up- or downregulated in centenarians showed the same response to 
ectopic expression of p21, yielding a putative ―p21-centenarian‖ signature 
 
Control 
lentivirus 
p21 
lentivirus 
p21 
lentivirus 
Control 
lentivirus 
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8.2.2 The p21-centenarian signature genes 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The tables above list the p21-centenarian-signature genes. The raw data relative to the 
subset of genes that were up- or downregulated in centenarians show a concordant 
response to the ectopic expression of p21 (WI38 vec =control, WI38 p21= WI38 cells 
transfected with p21 lentivirus vector) 
 
 
 
down in cent over old and down in p21 
WI-38 vec or p21   
Sample 
Name ()* W1-38 vec  W1-38 p21  
Systematic Raw Raw Common 
238420_at 283.1722 226.3846 TAOK1 
204969_s_at 465.4081 228.6547 RDX 
244187_at 971.4686 571.0795 SATL1 
213023_at 171.0369 122.6468 UTRN; DRP; DMDL; DRP1; FLJ23678 
205018_s_at 967.8409 872.7402 MBNL2 
204841_s_at 277.5317 218.18 EEA1; ZFYVE2 
    
 
up in cent over old and up in p21 
WI-38 vec or p21   
Sample 
Name ()* W1-38 vec  W1-38 p21 U133_2.txt 
Systematic Raw Raw Common 
236798_at 316.8349 456.0996  
202086_at 62.55866 2620.27 MX1; MxA; IFI78; IFI-78K 
209911_x_at 1570.459 3618.715 
HIST1H2BD; H2B/b; H2BFB; H2B.1B; 
HIRIP2; MGC90432; dJ221C16.6 
201272_at 5672.731 16654.81 AKR1B1; AR; ADR; ALDR1; MGC1804 
228275_at 285.584 531.0973  
39402_at 28.33118 179.7332 IL1B; IL-1; IL1F2; IL1-BETA 
209841_s_at 1618.85 2267.344 
DKFZp761K2424; NLRR3; NLRR-3; 
FLJ11129; LRRN3 
204014_at 23.40486 33.5471 DUSP4; TYP; HVH2; MKP2; MKP-2 
209840_s_at 1062.826 1525.926 LRRN3 
206197_at 14.67919 29.44429 NME5; NM23H5; NM23-H5 
219352_at 30.15033 460.1755 HERC6; FLJ20637 
232925_at 23.82106 29.10596  
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8.3 DNA damage response of the p21-centenarian signature genes showing 
a correlation  stress/aging  tested by RT-QPCR in an additional set of  
 young and old samples (15) treated with p21-inducing drug doxorubicin 
 
8.3.1 DNA damage response of the p21-centenarian signature genes showing 
a correlation  stress/aging  in Young subjects 
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Figure 16 
 
Figure 15-16: DNA damage response of the p21-centenarian signature genes showing a 
correlation stress/aging  was tested by RT-QPCR in an additional set of  young and old 
samples treated with p21-inducing drug doxorubicin . 
Rapresented In red the induced genes of the p21-centenarian signature , in green the 
downregulaed ones. 
 The data above are relative to the response to stress in Young Subjects .  
Some genes up regulated or downregulate in the p21-centenarian signature showed 
concordant response in the subset of  young subjects samples. Notably Il1 Beta, MX1 
and utrophin are strongly upregulated upon stress in Young subjects. (figure 16) 
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8.3.2 DNA damage response of the p21-centenarian signature genes showing 
a correlation  stress/aging  in old people 
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Figure 17 
 
 
 
Figure 17: DNA damage response of the p21-centenarian signature genes showing a 
correlation stress/aging tested by RT-QPCR in an additional set old samples treated 
with p21-inducing drug doxorubicin. 
Represented In red the induced genes of the p21-centenarian signature, in green the 
downregulaed ones. 
 
Some genes up regulated or downregulate in the p21-centenarian signature showed 
concordant response in the subset of  old subjects samples.  
 
Interestingly, same genes showed different behavior in the old subjects compared to the 
young ones. Il1 beta is much strongly induced in the young subjects , like also MX1 . 
Flj206 is downregulated in old people upon stress while is upregulated in young 
subjects as well for HERC6. 
 Finally strongest differences are found in the Utrophin gene behaviour upon stress: in 
Young people it is strongly induced, in old  the gene is downregulated. 
More details are showed in the following figure. 
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8.3.3 Utrophin : an age-dependent response to DNA damage   
 
 
UTROPHIN 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18 
 P<0. 03(t-test) 
 
Figure 18: response for the gene Utrophin (gene comprising the p21-centenarian 
signature) to Doxorubicin treatments in dermal fibroblast from individuals of different 
ages (The age of each individual is indicated above) 
 In yellow values relative to young people, in blue the one relative to old ones.  
Utrophin is one of the gene of the p21-centenarian signature showing the strongest 
differences in the response to the DNA damaging agent doxorubicin. 
Notably the gene is generelly upregulated in young sujbects upon and downregulated in 
old subjects upond treatment with Doxorubicin.  
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8.3.4 GENERALITIES ABOUT UTROPHIN  
Utrophin is a protein of the cytoskeleton. Utrophin was found during research into 
Duchenne's muscular dystrophy. The name is a contraction for ubiquitous dystrophin. 
The 900 kb gene for utrophin is found on the long arm of human chromosome 6. 
Utrophin was discovered due to its homology with dystrophin. It was found by 
screening a peptide containing the C-terminal domain of dystrophin against cDNA-
libraries. The homology varies over its full length from less than 30% in regions of the 
central rod structural domain, to 85% (identity 73%) for the actin binding domain. 
The tertiary structure of utrophin contains a C-terminus that consists of protein-protein 
interaction motifs that interact with dystroglycan, a central rod region consisting of a 
triple coiled-coil repeat, and an actin-binding N-terminus. 
In normal muscle cells, utrophin is located at the neuromuscular synapse and 
myotendinous junctions. It is necessary for normal membrane maintenance, and for the 
clustering of the acetylcholine receptor. In adult humans, utrophin RNA is found 
ubiquitously, as the name implies, being abundant in the brain, kidney, liver, lung, 
muscle, spleen and stomach. In the human fetus during muscle differentiation, utrophin 
is found at the sarcolemma. It disappears when the fetus begins to express dystrophin. 
Utrophin expression is dramatically increased in patients with Duchenne's muscular 
dystrophy (and female carriers), both in those muscle fibers lacking dystrophin and in 
rare, revertant fibers that express dystrophin. 
No reports have yet associated mutation in the utrophin gene with disease, but it does 
not seem to play a critical role in development, since mice without utrophin develop 
normally. 
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8.4 Basal levels of the p21-centenarian signature genes showing 
a correlation  stress/aging  tested by RT-QPCR in an additional set of  
 young and old samples (15)  
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               figure 19: basal levels-Young subjects 
 
Basal levels - Old people
0
0.5
1
1.5
2
2.5
figure 20: basal levels –old subjects 
 
figure 19-20 
Basal levels of the p21-centenarian segnature genes were tested by RQ_PCR in the an  
additional set of  young and old samples (15)  
The basal levels of the p21-centenarian genes are , as showed in the microarrays  analysis 
, are similar among young and old people. 
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8.5 Microarrays on an additional set of samples 
 
We have extended  the study to a set of fibroblast samples 15 (5 young, 4 old, 5 >90 y.o 
subjects) before and upon treatment with the DNA damaging agent  Doxorubicin in 
order to evaluate whether the the data obtained are confirmed.  
We recently got  the program Genespring update in order to read the results from exon.1 
chips. The analysis is in progress. 
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DISCUSSION 
 
CHAPTER 9: Project #1  
  
Identification of polymorphic variants in the p21 gene and their possible 
involvement in longevity 
 
Induction of cyclin-dependent kinase inhibitor p21(Waf1/Cip1/Sdi1) triggers cell 
growth arrest associated with senescence and damage response.  
In 2000 a paper from Roninson’ lab came out showing that p21  also up-regulates 
multiple genes that have been associated with senescence or implicated in age-related 
diseases.  
 
The main goal of this study consisted in testing the hypothesis that  there are 
polymorphisms in the p21 gene that characterize the centenarian population and may 
affect the induction of  the p21 regulated genes involved in age-related disease and 
eventually implicated in longevity and healthy aging.  
Centenarians exhibiting not only an extreme longevity but having also have delayed, 
survived or escaped diseases associated with the aging process (such as cardiovascular 
disease, Alzheimer's disease, and some types of cancer) are an ideal group of people for 
the study of specific genes that are either directly associated with longevity or enable 
people to escape or delay the effects of age-related diseases. 
 
The study was carried out in different steps by first sequencing  the p21 gene and 
promoter using DNA from 10 centenarians in order to identify polymorphic variants 
and their frequencies in the centenarian population.  Then we used the Sequenom 
strategy to determine the frequencies of the polymorphisms in about 100 individuals in 
the general population in order to identify polymorphisms that are present at a lower 
frequencies in the general population. 
 
By  sequencing of the 3 exons of the gene p21 we found an already characterized 
polymorphic variant which leads to a transition A transition A->C  at codon codon 31 
which leads to Arg-> Ser.  
Accordingly to the data published on NCBI, this polymorphic variant is present in the 
general population at a similar frequencies found in  the DNA of centenarian sequenced  
Sequencing the whole promoter lead us to find out that the promoter is strongly 
characterized by polymorphic variants.  
Infact, sequencing of the whole promoter lead us to the identificaty  29 polimorphic 
variants. 
Even tough just  2.5 kb of the promoter have been so far extensively studied most of the 
polymorphic variants have been already found by others so reported on NCBI but only 
few frequencies were known in the general population. 
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To have a better understanding of the frequencies of the whole polymorphic variants in 
the general population we used the Sequenom Strategy on about ~100 individual in the 
general population. 
The analysis trough haplomap highlighted the presence of an Haplotype , a combination 
of alleles at multiple linked loci that are transmitted together. The Haplotype 
characterized by 10 polymorphic variants, is  located in ~-4/-5 kb and located in the 
region where a novel p53 binding site has been recently found (Saramaki et al.,2006).  
The  frequencies of the haplotype carriers (almost all in etherozigoses) are (50%) 
centenarians  and (23%) for the general population with a P< 0.158 (t-test) , indicative 
of a trend. 
 
As far the other polymorphic variants we found another potential interesting one, a SNP 
(#16) located in proximity of the other p53 binding site (-2.300) as well p73 binding 
site.  
The majority of the polymorphic variants, however, showed similar frequencies in the 
centenarian and general population. This, indirectly, is an indication of the validity of 
the sequencing results. 
 
The siginificance of haplotype representation (as well the frequencies of the other 
polymorphic variants) is being verified by using Sequenom to determine the frequency 
of polymorphisms in ~200 centenarians and additional ~200 individuals in the general 
population.   
 
 
In the meantime, I carry out functional studies (luciferase assays) for those polymorphic 
variants centenarian-specific in order whether the putative-centenarian - haplotype 
affects the p21 promoter activity. 
In order to perform this study, it has been necessary to clone the whole promoter in 
plasmid contain the Luciferase reporter gene.  
Thus I obtained the two plasmid representative of the centenarian-haplotype promoter 
and of the general population haplotype one.  
 
The Luciferase assays were carried out on cells HCT116  (p53 WT and p53 null) 
transiently transfected with p21-Luc plasmids containing the 2 haplotype variants, p21 
N (common population haplotype) and p21-C (centenarian population haplotype) . 
The assays carried out with a single preparation of the common (p21N) and centenarian 
(p21C) promoter haplotypes, showed that both promoter alleles were 2-fold more active 
in the presence of p53: so in conclusion there is no difference in p53 response. 
The initial assay suggested also ~2-fold decrease in the basal promoter activity in the 
centenarian haplotype.  
In order to confirm this data the assays has been repeated in  three independent DNA 
preparations which did not confirm the originally observed difference in basal promoter 
levels, despite the first two plasmids preparation showed similar quality.  
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Anyway, despite similar basal promoter activities and p53 response, as discussed in the 
introduction, there are many potential physiological situations p53 indepentent where 
the response of the two alleles may be different . 
Interestingly the p21 promoter is induced by some signals involved in stress response 
and inflammation like TGF beta, INF Gamma, IL6  that, as discussed above, plays an 
important role in longevity (see inflammaging).  
 
In conclusion the p21 promoter appears to represent a unique sensor that is able to 
integrate many extracellular stress signals into cellular decisions . the p21 promoter, 
regulated not only by p53 but also by a variety of very different extracellular signals  , 
may generate different response depending on environmental factors and  haplotype 
variants affected.   
 
 
 
 
 
 
 
 
 
CONCLUSIONS #1 
 
We tested the hypothesis that p21 is involved in longevity: 
• We sequenced the gene and its promoter in 10 centenarians and found the total 
of 31 SNPs 
• Out of 29 promoter SNPs 6 were previously unreported and 23 had no known 
frequencies 
• We compared the frequencies of the SNPs in 10 centenarians and 92 members 
of general population 
We found 
• HAPLOTYPE located in -5kb region of the p21 promoter whose frequency is ~ 
2 fold higher in centenarians than in the general population 
• Large-scale analysis of haplotype frequencies is currently in progress 
• The ―centenarian‖ haplotype doesn’t affect the basal p21 promoter activity or its 
response to p53 
• There are many other possible physiological conditions in which the 
centenarian allele of the p21 promoter may potentially show a different  
response (IL6, IFN,progesterone, vitamin E, Vitamin D etc) 
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CHAPTER 10: Project #2 
 
Evaluation the differences in gene expression between centenarians, elderly, young 
in dermal fibroblast cultures and their response to p21 and DNA damage. 
 
Aging is characterized by a deleterious and progressive decline in physiological 
effieciency.  
It has been proposed the view that aging is a remodeling process where the body of 
survivors progressively adapts to internal and external damaging agents they are 
exposed to during several decades and their lifetime. Since multiple factors are involved 
in the aging process, it is still difficult to collectively understand the global network 
involved. 
cDNA microarrays becomes a growing technology which can be used to better 
understand the global networking of individual genes. Thus in this study , we used 
cDNA micorarrays to investigate  the relationship between DNA damage response and 
age related changes in gene expression.  
Microarrays analysis were performed on actively dividely dermal fibroblasts cultures 
from subject young, elderly and centenarians treated and untreated with the DNA 
damaging agent doxorubicin which in turn acts inducing oxidative stress (thus cell 
senescence) and p21. 
We used the unique materials from centenarians who can be considered as the best 
model of healthy aging and at the same time, intriguitly enough, they are also by 
definition extremely old people and show all the signs and the characteristics of a 
prolonged aging process. 
 
Here first, by performing Microarrays analysis (using the program Genespring) analysis 
of gene expression in 10 cultures from individuals of different ages we  identified genes 
showing age correlations (pilot study) thus elaborating a signature of genes that are 
upregulated or downreguated in centenarians compared to old people. (see table and 
list)  
Interestingly we found major differences comparing old and centenarians than 
comparing young and centenarian subjects.  
The centenarian ―signature‖ was then tested in other different models particularly,  we 
wanted to correlate age-specific difference in gene expression with transcriptional 
effects of p21. 
       To carry out this step we compared the data obtained from the Microarray analysis 
of gene expression from individuals of different ages, with the Microarrays data relative 
to  fibroblast WI38 transfected with a lentivirus which induces an ectopic expression of 
p21. (see figure)  
Interestingly, we found that  a subset of genes that were up- or downregulated in 
centenarians showed the same response to ectopic expression of p21, yielding a putative 
―p21-centenarian‖ signature. 
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Some of those genes are involved in stress response and inflammation such as IL1beta, 
MX1, other in signal transduction such as TAOK but all are interestingly downstream 
of p21 , so stress responsive genes.  
 
We then wanted to determine the determine the effects of DNA damage (which induces 
p21) on the expression of identified genes (trough RQ-PCR ) in independent samples 
treated with the agent Doxorubicin which induces oxidative stress and p21.  
 
Carrying out RQ-PCR assays on a subset of 14 samples for the main genes of the 
signature we found out that some genes differently respond to stress in young and old 
subjects such as Utrophin, flj206, Il1beta, MX1 .  
           Strikingly, upon stress, utrophin is generally downregulated in old people while 
it is upregulated in young subjects. (p<0.03) 
Utrophin is is a protein of the cytoskeleton that was found during research into 
Duchenne's muscular dystrophy . Its functions is not really known : in case the 
behaviour of this gene were confirmed by our microarrays results (analysis in progress), 
it would be  interesting to evaluate its functions. 
      The studies also highilighted that Il1 beta and MX1 are strongly upregulated in 
young people while weakly upregulated in old subjects (Il1beta) or downregulated 
(MX1).  
The gene fjl206 and Herc6  are still generally upregulated in young people and 
downregulated in old people.  
We also found genes such as TaoK and Radixin that show similar behaviour upon stress 
in the two groups, being both downregulated upon stress in young and old people.  
Taok and Radixin are also the downregulated ones in the p21-centenarian signature (i.e. 
genes downregulated in centenarians compared to old people and downregulated by p21 
induction).  
The basal levels of those genes of the p21-centenarian signature genes are, as expected, 
expressed at similar levels in young and old people confirming the data obtained trough 
microarrays analysis.  
 
Summarizing , the data obtained trough microarrays and RQ-PCR lead us to identified 
genes showing a strong relationship between p21-mediated damage response and aging  
Testing the DNA damage response of the p21-centenarian signature genes showing a 
correlation stress/aging  by RT-QPCR in an additional set of  young and old samples 
(15) treated with p21-inducing drug doxorubicin, we  found out that there is a subset of 
genes regulated by p21 that responde to stress in an age-specific manner. 
We are postulating that there are changes in gene expression due to the interaction with 
enviromental factors might be gradually ―fixed‖ in certain highly stress responsive 
genes thus resulting in a ―Memory of stress‖ and that p21 may have a role in this 
process. 
 
we  extended the study to a set of fibroblast samples 15 (5 young, 4 old, 5 >90 y.o 
subjects) before and upon treatment with the DNA damaging agent  Doxorubicin 
performing other Microarrays on those 15 subjects (under analysis). 
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CONCLUSIONS #2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
• The “Memory of stress” hypothesis is being tested by microarray 
analysis of doxorubicin response in cultures from 14 indivuduals of 
different ages 
 
 by RT-PCR in an independent set of 14 fibroblast cultures  from 
subject of different ages treated with the p21-inducing DNA-
damaging drug doxorubicin We found that some genes of the putative 
p21-centenarian signature showed a response aging-specificto stress  
 -the gene utrophin is an example of gene showing the corresponding 
response to p21-inducing DNA-damaging drug doxorubicin 
 
 
 
 
 
 
• These findings suggested the “memory of stress” hypothesis that 
postulates that some of the p21-mediated changes in gene expression 
become “fixed” over time in centenarians 
 
• A subset of genes that were up- or downregulated in centenarians 
showed the same response to ectopic expression of p21, yielding a 
putative “p21-centenarian” signature 
 
• Microarray analysis of gene expression in dermal fibroblast cultures 
from ten individuals of different ages yielded a tentative “centenarian 
signature” 
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GENERAL CONCLUSION  
 
 
This work of this PhD thesis has been focused on elucidating the relationship between 
stress response mechanisms and aging (and healthy aging)  carrying out two project that 
investigated the same problem from different angles.  
 
One of the most fascinating theory of aging postulates that aging is a remodeling 
process where the body of survivors progressively adapts to internal and external 
damaging agents they are exposed to during several decades.  
In this sense , stress response and adaptation mechanisms play a fundamental role in the 
aging process where the capability of adaptating effects, certainly, also is related the 
lifespan of  each individual.  
A key gene linking aging to stress response is indeed p21, an induction of cyclin-
dependent kinase inhibitor which triggers cell growth arrest associated with senescence 
and damage response and notably is involved in the up-regulation of  multiple genes 
that have been associated with senescence or implicated in age-related .  
 
For this reason p21 is a interesting candidate gene linking stress response mechanisms, 
aging and potentially longevity.  
 
Trough my the first part of this PhD project we  tested the hypothesis that there are  
polymorphic variants in the p21 gene possibly involved in longevity. 
          By sequencing the whole gene and the promoter in the DNA from centenarians 
and general population we identified an haplotype potentially involved in longevity 
located in -4 kb of the promoter and in proximity of a novel p53 binding site. 
Trough functional studies we also highlighted that the haplotype doesn’t effect the 
response to p53 and the the basal promoter activity is similar to the variant more 
common in the general population. However, as discussed above , there are many 
different physiological situation in which the centenarian-haplotype and the general-
population one might responde differently.  
 
In the second study we investigate the relationship between stress response and aging 
from a ―gene expression‖ point of view using Microarrays analysis on actively dividely 
dermal fibroblasts cultures from subject young, elderly and centenarians treated and 
untreated with the DNA damaging agent doxorubicin which in turn acts inducing 
oxidative stress (thus cell senescence) and p21. 
         we elaborate a gene expression signature of longevity and found that  a subset of 
genes that were up- or downregulated in centenarians showed the same response to 
ectopic expression of p21, yielding a putative ―p21-centenarian‖ signature. 
 
We tested the genes of the signature trough  RT-PCR in an independent set of 14 
fibroblast cultures  from subject of different ages treated with the p21-inducing DNA-
damaging drug doxorubicin .  
We  highlighted that some genes of the putative p21-centenarian signature responde to 
stress in a aging-specific manner . 
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These findings suggested the ―memory of stress‖ hypothesis that postulates that some of 
the p21-mediated changes in gene expression become ―fixed‖ over time in centenarians. 
We are currently thesting this hypothesis by microarray analysis of doxorubicin 
response in cultures from 14 indivuduals of different ages . 
        
We are also extending the study to other models (c.elegans) thanks to a collaboration set 
up with Dr. Dillin at Salk Institute where they are evaluating the role of some of the 
p21-centenarian signature genes in c.elegans .  
         The Dillin Lab is going to perform RNAi on long lived mutant worms to 
evaluated whether the long lived phenotype  may become suppressed.  
 
The concept of ―fixation‖ of stress,  memory of stress hypothesis that we are proposing 
has some interesting overlaps with some findings just recently pubblished by Lu et al., 
investigating gene regulation and DNA damage in the ageing human brain. (see 
Background) 
             Lu et al., examined the promoters of 30 different genes and they observed that 
DNA damage targeted the promoter of genes that are repressed with age but did not 
affected or that increase expression with age.  
They suggested that selective DNA damage gene promoter sequences is a potential 
mechanism whereby the expression of specific genes could register the passage of time.           
 
Some of the mechanisms of ―registration‖ of passage of time could be epigenetics, 
infact just recently another paper came out suggesting that DNA methylation in the 
human cerebral cortex is dynamically regulated throughout the life span (Siegemund et 
al.,). 
 
The concept of ―registering‖ the passage of time thus the idea of a memory of ―stress‖ 
are hopefully opening new scenario to the examination of aging from novel prospective 
where pilot genes involved in stress such as p21 might have a key role.  
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